ZoomInfo Technologies Inc
For the period ended Dec 31, 2024. Filed Feb 25, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 25, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Consolidated Financial Statements
ZoomInfo Technologies Inc. and Subsidiaries
Notes to Audited Consolidated Financial Statements
(In millions, except share/unit data and per share/unit amounts, unless otherwise noted)
| Note 1 | Basis of Presentation and Summary of Significant Accounting Policies | 75 |
|---|---|---|
| Note 2 | Revenue from Contracts with Customers | 85 |
| Note 3 | Business Combinations | 87 |
| Note 4 | Cash, Cash Equivalents, and Short-term Investments | 89 |
| Note 5 | Property and Equipment | 90 |
| Note 6 | Goodwill and Acquired Intangible Assets | 90 |
| Note 7 | Financing Arrangements | 92 |
| Note 8 | Derivatives and Hedging Activities | 94 |
| Note 9 | Fair Value | 95 |
| Note 10 | Commitments and Contingencies | 97 |
| Note 11 | Stockholders' Equity | 100 |
| Note 12 | Earnings Per Share | 101 |
| Note 13 | Leases | 102 |
| Note 14 | Equity-based Compensation | 105 |
| Note 15 | Segment and Geographic Data | 109 |
| Note 16 | Tax Receivable Agreements | 110 |
| Note 17 | Income Taxes | 111 |
| Note 18 | Subsequent Events | 114 |
Note 1 - Business, Basis of Presentation, and Summary of Significant Accounting Policies
Business
ZoomInfo Technologies Inc., through its operating subsidiaries, (the “Company”, “we”, “us”, “our”, and “ZoomInfo”) provides a go-to-market intelligence and engagement platform for sales, marketing, operations, and recruiting professionals. The Company’s cloud-based platform provides workflow tools with integrated, accurate, and comprehensive information on organizations and professionals to help users identify target customers and decision makers, obtain continually updated predictive lead and company scoring, monitor buying signals and other attributes of target companies, craft messages, engage via automated sales tools, and track progress through the deal cycle.
The Company headquarters are located in Vancouver, WA, and we have additional offices throughout the United States, and in Israel, Canada, the United Kingdom, and India.
Accounting Principles
Our consolidated financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).
Use of Estimates
The preparation of consolidated financial statements in conformity with U.S. GAAP requires us to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements, as well as the reported amounts of revenue and expenses during the reporting period. We base these estimates on historical and anticipated results, trends, and other assumptions with respect to future events that we believe are reasonable and evaluate our estimates on an ongoing basis. Given that estimates and judgments are required, actual results may differ from our estimates and such differences could be material to our consolidated financial position and results of operations.
Principles of Consolidation
The consolidated financial statements include the accounts of ZoomInfo Technologies Inc. and its subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation.
Revenue Recognition
The Company derives revenue primarily from subscription services. Our subscription services consist of our software as a service (“SaaS”) applications and related access to our platform. Subscription contracts are generally based on the number of users that access our applications, the level of functionality that they can access, and the amount of data that a customer integrates with their systems. Our subscription contracts typically have a term ofone tothree years and are non-cancelable. We typically bill for services annually, semi-annually, or quarterly in advance of delivery.
The Company accounts for revenue contracts with customers through the following steps:
(1)Identify the contract with a customer;
(2)Identify the performance obligations in the contract;
(3)Determine the transaction price;
(4)Allocate the transaction price; and
(5)Recognize revenue when or as the Company satisfies a performance obligation.
We recognize revenue for subscription contracts on a ratable basis over the contract term based on the number of calendar days in each period, beginning on the date that our service is made available to the customer. Unearned revenue results from revenue amounts billed to customers in advance or cash received from customers in advance of the satisfaction of performance obligations. Determining the transaction price often involves judgment and making estimates that can have a significant impact on the timing and amount of revenue reported. At times, the Company may adjust billing under a contract based on the addition of services or other circumstances, which are accounted for as variable consideration. The Company estimates these amounts based on historical experience and adjusts revenue recognized.
Cash, Cash Equivalents, and Short-term Investments
Cash equivalents consist of highly liquid marketable debt securities with remaining maturities of three months or less at the date of purchase. We classify our investments in marketable securities as “available-for-sale.” We carry these investments at fair value, based on quoted market prices or other readily available market information. Unrealized gains and losses, net of taxes, are included in Accumulated other comprehensive income, which is reflected as a separate component of stockholders’ equity on our Consolidated Balance Sheets. Gains and losses are determined using the specific identification method and recognized when realized on our Consolidated Statements of Operations. If we were to determine that an other-than-temporary decline in fair value has occurred, the amount of the decline related to a credit loss will be recognized in income.
Fair Value Measurements
The Company measures assets and liabilities at fair value based on an expected exit price, which represents the amount that would be received on the sale of an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level. The following are the hierarchical levels of inputs to measure fair value:
Level 1 -Observable inputs that reflect unadjusted quoted prices in active markets for identical assets or liabilities
Level 2 -Other inputs that are directly or indirectly observable in the marketplace
Level 3 -Unobservable inputs that are supported by little or no market activity, including the Company’s own assumptions in determining fair value
The inputs or methodology used for valuing financial assets and liabilities are not necessarily an indication of the risk associated with investing in them.
Concentrations of Credit Risk and Significant Customers
Financial instruments that potentially subject us to concentrations of credit risk consist principally of cash and cash equivalents, short-term investments, and accounts receivable. The Company holds cash at major financial institutions that often exceed Federal Deposit Insurance Corporation (“FDIC”) insured limits. The Company manages its credit risk associated with cash concentrations by concentrating its cash deposits in high-quality financial institutions and by periodically evaluating the credit quality of the primary financial institutions holding such deposits. The carrying value of cash approximates fair value. Our investment portfolio is comprised of highly rated securities with a weighted-average maturity of less than 12 months in accordance with our investment policy which seeks to preserve principal and maintain a high degree of liquidity. Historically, the Company has not experienced any losses due to such cash concentrations. The Company does not have any off-balance sheet credit exposure related to its customers. Concentrations of credit risk with respect to accounts receivable and revenue are limited due to a large, diverse customer base. We do not require collateral from clients. We maintain an allowance for credit losses based upon the expected collectability of accounts receivable. The Company performs ongoing credit evaluations of its customers and maintains allowances for possible losses. No single customer accounted for 10% or more of our revenue for the years ended December 31, 2024, 2023, and 2022 or accounted for more than 10% of accounts receivable as of December 31, 2024 and 2023.
Accounts Receivable and Contract Assets
Accounts receivable represents billed transaction price from revenue contracts, reflecting adjustments for variable consideration, and is presented net of allowance for expected credit losses. It does not bear interest. We consider receivables past due based on the contractual payment terms. Management’s evaluation of the adequacy of the allowance for credit losses considers historical collection experience, changes in customer payment profiles, the aging of receivable balances, as well as current economic conditions, all of which may impact a customer’s ability to pay. Account balances are written-off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. As of December 31, 2024, the allowance for expected credit losses was $12.6 million. As of December 31, 2023, the allowance for expected credit losses was not significant to the accompanying consolidated financial statements. The Company reassesses the adequacy of the allowance each reporting period.
The assessment of variable consideration to be constrained is based on estimates, and actual consideration may vary from current estimates. As adjustments to these estimates become necessary, they are reported in earnings in the periods in which they become known. Changes in variable consideration are recorded as a component of net revenue.
Contract assets represent a contractual right to consideration in the future. Contract assets are generated when contractual billing schedules differ from revenue recognition timing.
Property and Equipment, Net
Property and equipment is stated at cost, net of accumulated depreciation and amortization. All repairs and maintenance costs are expensed as incurred. Depreciation and amortization costs are expensed on a straight-line basis over the lesser of the estimated useful life of the asset or the remainder of the lease term for leasehold improvements. Qualifying internal use software costs incurred during the application development stage, which consist primarily of internal product development costs, outside services, personnel costs (including equity-based compensation), and purchased software license costs, are capitalized and amortized over the estimated useful life of the asset. Estimated useful lives range from three toten years.
Deferred Commissions
Certain sales commissions earned by our sales force are considered incremental and recoverable costs of obtaining a contract with a customer. These sales commissions for initial contracts are capitalized and included in Deferred costs and other assets, net of current portion on our Consolidated Balance Sheets. Deferred sales commissions are amortized on a straight-line basis over the estimated period of benefit from the customer relationship which we have determined to be approximatelytwo andfour years for renewals and new clients, respectively. We determined the period of benefit by taking into consideration our customer contracts, our technology, and other factors. Amortization expense related to these capitalized commissions is included in Sales and marketing on our Consolidated Statements of Operations.
Commissions payable at December 31, 2024 were $32.8 million, of which the current portion of $30.8 million was included in Accrued expenses and other current liabilities on our Consolidated Balance Sheets, and the long-term portion of $2.0 million was included in Other long-term liabilities on our Consolidated Balance Sheets. Commissions payable at December 31, 2023 were $37.7 million, of which the current portion of $34.4 million was included in Accrued expenses and other current liabilities on our Consolidated Balance Sheets, and the long-term portion of $3.3 million was included in Other long-term liabilities on our Consolidated Balance Sheets.
Certain commissions are not capitalized as they do not represent incremental costs of obtaining a contract. Such commissions are expensed as incurred.
The Company capitalized $87.6 million, $85.5 million, and $79.9 million of costs to obtain revenue contracts and amortized $67.6 million, $75.3 million, and $65.9 million to Sales and marketing for the years ended December 31, 2024, 2023, and 2022, respectively. Costs capitalized to obtain a revenue contract, net on the Company’s Consolidated Balance Sheets totaled $103.3 million and $83.3 million as of December 31, 2024 and 2023, respectively. There wereno impairments of costs to obtain revenue contracts in the years ended December 31, 2024, 2023, and 2022.
Advertising and Promotional Expenses
The Company expenses advertising costs as incurred. Advertising expenses of $36.0 million, $31.3 million, and $28.8 million were recorded for the years ended December 31, 2024, 2023, and 2022, respectively. Advertising expenses are included in Sales and marketing on our Consolidated Statements of Operations.
Research and Development
Research and development expenses primarily consist of employee compensation such as salaries, bonuses, equity-based compensation, and other employee-related benefits for our engineering and product management teams, as well as overhead costs, and technology. We continue to focus our research and development efforts on developing new products, adding new features and services, integrating acquired technologies, and increasing functionality. Expenditures for software developed or obtained for internal use are capitalized and amortized over afour-year period on a straight-line basis.
Business Combinations
We allocate purchase consideration to the tangible assets acquired, liabilities assumed, and intangible assets acquired based on their estimated fair values. The purchase price is determined based on the fair value of the assets transferred, liabilities assumed and equity interests issued, after considering any transactions that are separate from the business combination. The fair value of equity issued as part of a business combination is determined based on grant date stock price of the Company. The excess of fair value of purchase consideration over the fair values of the identifiable assets and liabilities is recorded as goodwill. Such valuations require management to make significant estimates and assumptions, especially with respect to intangible assets and contingent liabilities. Significant estimates in valuing certain intangible assets include, but are not limited to, future expected cash flows from acquired customer bases, acquired technology and acquired trade names, useful lives, royalty rates, and discount rates.
The estimates are inherently uncertain and subject to revision as additional information is obtained during the measurement period for an acquisition, which may last up to one year from the acquisition date. During the measurement period, we may record adjustments to the fair value of tangible and intangible assets acquired and liabilities assumed, with a corresponding offset to goodwill. After the conclusion of the measurement period or the final determination of the fair value of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to earnings.
In addition, uncertain tax positions and tax-related valuation allowances assumed in connection with a business combination are initially estimated as of the acquisition date. We re-evaluate these items based upon the facts and circumstances that existed as of the acquisition date, with any revisions to our preliminary estimates being recorded to goodwill, provided that the timing is within the measurement period. Subsequent to the measurement period, changes to uncertain tax positions and tax-related valuation allowances will be recorded to earnings.
Goodwill and Acquired Intangible Assets
Goodwill is calculated as the excess of the purchase consideration paid in a business combination over the fair value of the assets acquired less liabilities assumed. Goodwill is not amortized and is tested for impairment at least annually during the fourth quarter of our fiscal year or when events and circumstances indicate that the fair value of a reporting unit may be below its carrying value. The Company hasone reporting unit.
We first assess qualitative factors to evaluate whether it is more likely than not that the fair value of a reporting unit is less than the carrying amount or elect to bypass such assessment. If it is determined that it is more likely than not that the fair value of the reporting unit is less than its carrying value, or we elect to bypass the qualitative assessment, we perform a quantitative test by determining the fair value of the reporting unit. If the carrying value of the reporting unit exceeds the fair value, then an impairment loss is recognized for the difference.
Acquired technology, customer relationships, trade names or brand portfolios, and other intangible assets are related to historical acquisitions (refer to Note 6 - Goodwill and Acquired Intangible Assets). Acquired intangible assets are amortized on a straight-line basis over the estimated period over which we expect to realize economic value related to the intangible asset. The amortization periods generally range from 2 years to 15 years. Any costs incurred to renew or extend the life of an intangible or long-lived asset are reviewed for capitalization.
Indefinite-lived intangible assets consist of brand portfolios acquired from Pre-Acquisition ZI and represent costs paid to legally register phrases and graphic designs that identify and distinguish products sold by the Company. Indefinite-lived intangible assets are not subject to amortization. Instead, they are subject to an annual assessment for potential impairment, or more frequently upon the occurrence of a triggering event when circumstances indicate that the book value is greater than its fair value. The Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than the carrying value as a basis to determine whether further impairment testing is necessary. The Company conducts its impairment assessment during the fourth quarter of each fiscal year. No impairment charges relating to acquired goodwill or indefinite-lived intangible assets were recorded for the years ended December 31, 2024, 2023, and 2022.
Impairment and Abandonment of Long-lived Assets
Long-lived assets, such as property and equipment, acquired intangible assets, and right-of-use assets, are reviewed for impairment whenever events or circumstances indicate that the carrying value of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the undiscounted future cash flows expected to be generated by the asset or group of assets. If the carrying amount of the asset exceeds the estimated future cash flows, an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the estimated fair value of the asset. The estimated future cash flows associated with the right-of-use assets under Accounting Standards Codification (“ASC”) 842 were developed by incorporating current market data and forecasts provided by reputable external real estate brokers and data sources. These projections consider prevailing rental rates, anticipated lease renewals, expected vacancy periods, and other relevant market factors that contribute to the estimation of recoverable cash flows for the impaired office spaces we do not intend to occupy. During the year ended December 31, 2024, we recorded impairment charges of $53.3 million, to reduce the carrying values of our existing right-of-use assets associated with our Ra’anana, Waltham, Vancouver, and Grand Rapids offices. During the year ended December 31, 2023, we recorded impairment charges of $5.2 million, to reduce the carrying value of the right-of-use assets associated with certain of our office spaces. No impairment charges were recorded for the year ended December 31, 2022.
When a lease right-of-use asset has been abandoned, the estimated useful life of the asset is updated to reflect the cease use date, and the remaining carrying value of the asset is amortized ratably over the period between the commitment date and the cease use date. During the year ended December 31, 2024, we recorded lease abandonment charges of $4.1 million, related to the accelerated amortization of right-of-use assets. No lease abandonment charges were recorded for the years ended December 31, 2023 and 2022, respectively.
Leases
We determine if an arrangement is or contains a lease at contract inception. For these arrangements, primarily those related to our data center arrangements, there is judgment in evaluating if the arrangement involves an identified asset that is physically distinct or whether we have the right to substantially all of the capacity of an identified asset that is not physically distinct. In arrangements that involve an identified asset, there is also judgment in evaluating if we have the right to direct the use of that asset.
We do not have any finance leases. Operating leases are recorded on our Consolidated Balance Sheets. Right-of-use assets and lease liabilities are measured at the lease commencement date based on the present value of the fixed minimum remaining lease payments over the lease term, determined using the discount rate for the lease at the commencement date. Because the rates implicit in our leases are not readily determinable, we use our incremental borrowing rate as the discount rate for each respective lease, which approximates the interest rate at which we could borrow on a collateralized basis with similar terms and payments and in similar economic environments. Some leases include options to extend or options to terminate the lease prior to the stated lease expiration. Optional periods to extend a lease, including by not exercising a termination option, are included in the lease term when it is reasonably certain that the option will be exercised (or not exercised in the case of termination options). Operating lease expense is recognized on a straight-line basis over the lease term. We account for lease and non-lease components, principally common area maintenance and related taxes for our facilities leases, as a single lease component. Short-term leases, defined as leases having an original lease term less than or equal to one year, are excluded from our right-of-use assets and lease liabilities.
Derivative Instruments and Hedging Activities
FASB’s ASC 815—Derivatives and Hedging (“ASC 815”), provides the disclosure requirements for derivatives and hedging activities with the intent to provide users of financial statements with an enhanced understanding of: (a) how and why an entity uses derivative instruments, (b) how the entity accounts for derivative instruments and related hedged items, and (c) how derivative instruments and related hedged items affect an entity’s financial position, financial performance, and cash flows. Further, qualitative disclosures are required that explain the Company’s objectives and strategies for using derivatives, as well as quantitative disclosures about the fair value of and gains and losses on derivative instruments, and disclosures about credit risk-related contingent features in derivative instruments.
As required by ASC 815, the Company records all derivatives as either assets or liabilities on our Consolidated Balance Sheets and measures them at fair value. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting, and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Derivatives designated and qualifying as a hedge of the exposure to changes in the fair value of an asset, liability, or firm commitment attributable to a particular risk, such as interest rate risk, are considered fair value hedges. Derivatives designated and qualifying as a hedge of the exposure to variability in expected future cash flows, or other types of forecasted transactions, are considered cash flow hedges. Derivatives may also be designated as hedges of the foreign currency exposure of a net investment in a foreign operation. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting. To receive hedge accounting treatment, all hedging relationships are formally documented at the inception of the hedge, and the hedges must be highly effective in offsetting changes to future cash flows on hedged transactions.
Unearned Revenue
Unearned revenue consists of customer payments and billings in advance of revenue being recognized from our subscription services. Unearned revenue that is anticipated to be recognized within the next 12 months is recorded as Unearned revenue, current portion and the remaining portion is included in Unearned revenue, net of current portion on our Consolidated Balance Sheets.
Debt Issuance Costs
Costs incurred in connection with the issuance of long-term debt are deferred and amortized as interest expense over the terms of the related debt using the effective interest method for term debt and on a straight-line basis for revolving debt. Debt issuance costs are generally presented on our Consolidated Balance Sheets as a direct deduction from the carrying amount of the outstanding borrowings, consistent with debt discounts. However, the Company classifies the debt issuance costs related to its first lien revolving credit facility within Deferred costs and other assets, net of current portion on our Consolidated Balance Sheets regardless of whether the Company has any outstanding borrowings on our first lien revolving credit facility. Upon a refinancing or amendment, the Company evaluates the modified debt instrument in accordance with ASC 470-50-40-10. When the present value of the cash flows under the modified debt instrument has changed by greater than 10 percent from the present value of the remaining cash flows under the terms of the original debt instrument, the Company accounts for the amendment as a debt extinguishment and all previously-capitalized debt issuance costs are expensed and included in Loss on debt modification and extinguishment. If the change in the present value of cash flows is less than 10 percent, any previously-capitalized debt issuance costs are amortized as interest expense over the term of the new debt instrument. The Company performs assessments of debt modifications at a lender-specific level for all syndicated financing arrangements.
In connection with our IPO, we entered intotwo Tax Receivable Agreements with certain non-controlling interest holders (the “TRA Holders”). The TRAs generally provide for payment by the Company to the TRA Holders of 85% of the net cash savings, if any, in U.S. federal, state and local income tax or franchise tax based on income that the Company actually realizes or is deemed to realize in certain circumstances. The Company will retain the benefit of the remaining 15% of these net cash savings.
We account for amounts payable under the TRA in accordance with ASC Topic 450, Contingencies. Amounts payable under the TRA are accrued by a charge to income when it is probable that a liability has been incurred and the amount is estimable. TRA related liabilities are classified as current or noncurrent based on the expected date of payment and are included on our Consolidated Balance Sheets under the captions Current portion of tax receivable agreements liability and Tax receivable agreements liability, net of current portion, respectively. Subsequent changes to the measurement of the TRA liability are recognized in our Consolidated Statements of Operations as a component of Other loss (income), net. Refer to Note 16 - Tax Receivable Agreements for additional information.
Income Taxes
The Company recognizes deferred tax assets and liabilities based on the differences between the financial statement carrying amounts and the tax bases of existing assets and liabilities using tax rates expected to be in effect in the years in which the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance if it is more likely than not that some portion or all of the deferred tax assets will not be realized.
The Company recognizes the tax benefit of an uncertain tax position only if it is more likely than not that the position is sustainable upon examination by the taxing authority, based solely on its technical merits. The tax benefit recognized is measured as the largest amount of benefit which is greater than 50 percent likely to be realized upon settlement with the taxing authority. The Company recognizes interest and penalties within Provision for income taxes on the Consolidated Statements of Operations. Refer to Note 17 - Income Taxes for additional information.
Equity-Based Compensation Expense
The Company periodically grants incentive awards to employees and non-employees, which generally vest over periods of up tofour years. Incentive awards may be in the form of various equity-based awards such as common stock, subject to certain specified restrictions (which may include, without limitation, a requirement that the recipient remain continuously employed or provide continuous services for a specified period of time), granted under Section 8 of the 2020 Omnibus Incentive Plan (“Restricted Stock”) and an unfunded and unsecured promise to deliver shares of our common stock, cash, other securities or other property, subject to certain restrictions (which may include, without limitation, a requirement that the recipient remain continuously employed or provide continuous services for a specified period of time), granted under Section 8 of the 2020 Omnibus Incentive Plan (“Restricted stock units”, or “RSU”), and common stock options.
Compensation expense for incentive awards is measured at the estimated fair value of the incentive units and is included as compensation expense over the vesting period during which an employee provides service in exchange for the award. Compensation expense for performance-based restricted stock units is measured at the estimated fair value of the units and is recognized using the accelerated attribution method over the service period when it is probable that the performance condition will be satisfied. Compensation expense for market-based restricted stock units is measured at the estimated fair value using a Monte Carlo simulation model, which requires the use of various assumptions, including the stock price volatility and risk-free interest rate as of the valuation date corresponding to the length of time remaining in the performance period. This expense is recognized using the accelerated attribution method over the service period and is not reversed if the market condition is not met.
The Company uses a Black-Scholes option pricing model to determine the fair value of stock options. The Black-Scholes option pricing model includes various assumptions, including the expected term of incentive units, the expected volatility, and the expected risk-free interest rate. These assumptions reflect the Company’s best estimates, but they involve inherent uncertainties based on market conditions generally outside the control of the Company. As a result, if other assumptions are used, compensation cost could differ.
Compensation expense related to the Company’s Employee Stock Purchase Plan is measured at the estimated fair value using the Black-Scholes option pricing model using the estimated number of awards as of the beginning of the offering period.
The Company measures employee, non-employee, and board of director equity-based compensation on the grant date fair value basis. Equity-based compensation expense is recognized over the requisite service period of the awards. For equity awards that have a performance condition, the Company recognizes compensation expense based on its assessment of the probability that the performance condition will be achieved. The Company has elected to account for forfeitures as they occur.
The Company classifies equity-based compensation expense on our Consolidated Statements of Operations in the same manner in which the award recipient’s salary and related costs are classified or in which the award recipient’s service payments are classified.
Bonus Accruals
The Company has bonus programs for eligible employees. Bonuses are determined based on various criteria, including the achievement of corporate, departmental, and individual goals. Bonus accruals are estimated based on various factors, including target bonus percentages per level of employee and probability of achieving the goals upon which bonuses are based. The Company’s management periodically reviews the progress made towards the goals under the bonus programs. As bonus accruals are dependent upon management’s judgments of the likelihood of achieving the various goals, it is possible for bonus expense to vary significantly in future periods if changes occur in those management estimates. Bonus accruals were $26.0 million and $25.5 million as of December 31, 2024 and 2023, respectively, and were included in Accrued expenses and other current liabilitieson our Consolidated Balance Sheets.
Employee Retirement Benefits
The Company has a 401(k) plan that all eligible employees can contribute pre-tax and after-tax (Roth) to up to the maximum annual amount established by the Internal Revenue Code. The Company matches 50% of the employee’s contribution to the 401(k) plan up to the first 7% of their contribution. Matching contributions made by the Company were approximately $9.7 million, $9.0 million, and $8.0 million for the years ended December 31, 2024, 2023, and 2022, respectively. Matching contributions vest 33% per year until fully vested after three years of employee service. Employee contributions are 100% vested immediately.
Israeli Severance Pay Law
Under Section 14 of the Israeli Severance Pay Law, employees in Israel are entitled to have monthly deposits, at a rate of 8.33% of their monthly salary, made on their behalf to their insurance funds which relieves the Company from future obligations under this law. During the years ended December 31, 2024, 2023, and 2022, the Company recorded $6.5 million, $7.0 million, and $7.2 million, respectively, in severance expenses related to these employees.
Governmental Assistance
The Company recognizes certain research and development tax credits as a benefit in the period in which the credit is generated under Government Assistance (Topic 832). This applies to credits that may be utilized against taxes other than income taxes. Under this policy, we recognize the benefit of tax credits as generated when we have reasonable assurance that (1) the Company complied with the conditions attached to the credits and (2) the credits will be received.
During 2024, we recorded a cumulative adjustment related to research and development tax credits earned in tax years 2021 through 2024. As a result, the Company recognized $1.9 million in research and development tax credits as a reduction to General and administrative expenses in the Consolidated Statements of Operations for the year ended December 31, 2024. As of December 31, 2024, the Company has recorded $0.4 million in Prepaid expenses and other current assets and $1.5 million in Deferred costs and other assets, net of current portion related to these credits on our Consolidated Balance Sheets. These amounts represent credits earned for qualifying research and development activities for which the Company has reasonable assurance of receipt but has not yet utilized against tax.
The recognition of these credits requires management to make estimates and assumptions regarding qualifying research and development expenses. The Company has determined it is probable that it will comply with the relevant conditions attached to the credits and they will be received based on the relevant taxing authorities’ research and development credit program and current operations.
Reclassifications
Certain reclassifications have been made in the notes to the consolidated financial statements to conform previously reported amounts to current year presentation. These reclassifications had no impact on the previously reported net income or comprehensive income.
Effective the second quarter of 2024, the Company removed the presentation of Restructuring and transaction-related expenses from the Consolidated Statements of Operations. These expenses will be allocated to the remaining financial statement line items. For comparability, the prior period amounts have been recast to reflect the current period presentation with no impact to net income or comprehensive income previously reported.
Recent Accounting Pronouncements
Recently Issued Accounting Pronouncements
In November 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires additional disclosure of the nature of expenses included in the income statement. The standard requires disaggregation of certain costs in a separate note to the financial statements, such as the amounts of employee compensation, depreciation, and intangible asset amortization, included in each relevant expense caption in annual and interim consolidated financial statements. This standard will be effective for the Company for the annual period beginning January 1, 2027 and interim period beginning January 1, 2028, with early adoption permitted. The requirements should be applied on a prospective basis while retrospective application is permitted. The Company is currently evaluating the disclosure impacts of ASU 2024-03 on its consolidated financial statements as well as the impacts to its financial reporting process and related internal controls.
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. The new standard will be effective for the Company for the annual period beginning January 1, 2025 on a prospective basis, with a retrospective option, and early adoption is permitted. The adoption of this standard only impacts annual disclosures and is not expected to have a material impact on the Company’s consolidated financial statements.
In October 2023, the FASB issued ASU 2023-06, Disclosure Improvements: Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative. The amendments in this ASU incorporate into the FASB’s ASC certain SEC disclosure requirements that were referred to the FASB and overlap with, but require incremental information to, U.S. GAAP. The effective date for each amendment will be the date on which the SEC’s removal of that related disclosure from Regulation S-X or Regulation S-K becomes effective, with early adoption prohibited, and applied prospectively. If by June 30, 2027, the SEC has not removed the applicable requirement from Regulation S-X or Regulation S-K, the pending content of the related amendment will be removed from FASB’s ASC and will not become effective for any entity. The Company does not expect this ASU to have a material impact on its consolidated financial statements.
Recently Adopted Accounting Pronouncements
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments in this ASU are intended to improve reportable segment disclosure primarily through enhanced disclosures about significant segment expenses. This standard is effective for fiscal years beginning after December 15, 2023 (i.e., a January 1, 2024 effective date), and interim periods within fiscal years beginning after December 15, 2024 (i.e., the first quarter of 2025). The amendments in this ASU should be applied retrospectively to all prior periods presented in the financial statements. Early adoption is permitted. The Company adopted this standard beginning in 2024 and all required segment-related disclosures under the standard will be provided within this Form 10-K, as well as within each subsequent interim report. However, there was no impact to the consolidated financial statements upon adoption.
Note 2 - Revenue from Contracts with Customers
Revenue comprised the following service offerings:
| Year Ended December 31, | |||
|---|---|---|---|
| (in millions) | 2024 | 2023 | 2022 |
| Subscription | $1,200.4 | $1,225.1 | $1,087.3 |
| Usage-based | 10.7 | 9.9 | 8.8 |
| Other | 3.2 | 4.5 | 1.9 |
| Total revenue | $1,214.3 | $1,239.5 | $1,098.0 |
Go-to-market business intelligence tools are subscription services that allow customers access to our SaaS tools to support sales and marketing processes, which include data, analytics, and insights to provide accurate and comprehensive intelligence on organizations and professionals. Our customers use our platform to identify target customers and decision makers, obtain continually updated predictive lead and company scoring, monitor buying signals and other attributes of target companies, craft messages, engage via automated sales tools, and track progress through the deal cycle.
Usage-based revenue is comprised largely of email verification and facilitation of online advertisements, which are charged to our customers on a per unit basis based on their usage. We regularly observe that customers integrate our usage-based services into their internal workflows and use our services on an ongoing basis. We recognize usage-based revenue at the point in time the services are consumed by the customer, thereby satisfying our performance obligation.
Other revenue is comprised largely of implementation and professional services fees. We recognize other revenue as services are delivered.
Of the total revenue recognized in the years ended December 31, 2024, 2023, and 2022, $424.9 million, $403.1 million, and $354.6 million were included in the unearned revenue balance as of December 31, 2023, 2022, and 2021, respectively. Revenue recognized from performance obligations satisfied (or partially satisfied) in previous periods was not material.
Note 2 - Revenue from Contracts with Customers (continued)
Contract Assets and Unearned Revenue
The Company’s standard billing terms typically require payment at the beginning of each annual, semi-annual, or quarterly period. Subscription revenue is generally recognized ratably over the contract term starting with when our service is made available to the customer. Usage-based revenue is recognized in the period services are utilized by our customers. The amount of revenue recognized reflects the consideration the Company expects to be entitled to receive in exchange for these services.
The Company records a contract asset when revenue recognized on a contract exceeds the billings to date for that contract. Unearned revenue results from cash received or amounts billed to customers in advance of revenue recognized upon the satisfaction of performance obligations. The unearned revenue balance is influenced by several factors, including seasonality, the compounding effects of renewals, invoice duration, invoice timing, dollar size, and new business timing within the quarter. The unearned revenue balance does not represent the total contract value of annual or multi-year, non-cancelable subscription agreements.
As of December 31, 2024 and 2023, the Company had contract assets of $5.0 million and $5.9 million respectively, which are recorded as current assets within Prepaid expenses and other current assetson our Consolidated Balance Sheets. As of December 31, 2024 and 2023, the Company had unearned revenue of $477.9 million and $441.9 million, respectively.
ASC 606 requires the allocation of the transaction price to the remaining performance obligations of a contract. Transaction price allocated to remaining performance obligations represents contracted revenue that has not yet been recognized, which includes unearned revenue and unbilled amounts that will be recognized as revenue in future periods. Transaction price allocated to remaining performance obligations is influenced by several factors, including seasonality, the timing of renewals, and disparate contract terms. Revenue allocated to remaining performance obligations represents contracted revenue that has not yet been recognized, which includes unearned revenue and backlog. The Company's backlog represents installment billings for periods beyond the current billing cycle. The majority of the Company’s noncurrent remaining performance obligations will be recognized in the next 13 to 36 months.
The remaining performance obligations consisted of the following:
| (in millions) | Recognized within one year | Noncurrent | Total |
|---|---|---|---|
| As of December 31, 2024 | $850.1 | $306.8 | $1,156.9 |
| As of December 31, 2023 | 856.4 | 296.5 | 1,152.9 |
Note 3 - Business Combinations
2022 Acquisitions
In April 2022, the Company acquired all the outstanding equity interests of Comparably, Inc. (“Comparably”) and acquired substantially all the assets and certain specified liabilities of Dogpatch Advisors, LLC (“Dogpatch”) (collectively, the “2022 Acquired Companies”) for a total purchase consideration of $150.6 million in cash and $10.0 million in convertible notes receivable. As part of the acquisitions, the Company issued 448,740 restricted stock units at a total grant date fair value of $26.8 million and could be required to issue additional equity awards up to a maximum value of $3.7 million based on the attainment of certain revenue thresholds and the continued employment of acquired employees. The acquisition of Comparably provides ZoomInfo with unique proprietary data to further build ZoomInfo Talent into a best-in-class talent platform by enriching recruiter search options and providing recruiters with access to millions of quality candidates and employer brand solutions. We acquired Dogpatch Advisors to launch ZoomInfo Labs, a new go-to-market thought leadership team, driving go-to-market data analysis, product enhancements and strategy for our enterprise customers. Dogpatch is a go-to-market consultancy with expertise in scaling revenue teams and building modern sales and marketing systems. The purchase accounting for the 2022 Acquired Companies transactions has been finalized.
The Company has included the financial results of the 2022 Acquired Companies in the consolidated financial statements from each date of acquisition. Due to the integration of the 2022 Acquired Companies into the operations of ZoomInfo, the Company cannot practicably determine the contribution of the 2022 Acquired Companies to consolidated net earnings. Transaction costs associated with each acquisition were not material.
The acquisition date fair value of the total consideration transferred was comprised of the following:
| (in millions) | Preliminary Fair Value at Acquisition Date | Measurement Period Adjustments | Adjusted Fair Value at Acquisition Date |
|---|---|---|---|
| Cash | $150.5 | $0.1 | $150.6 |
| Conversion of Note Receivable | 10.0 | — | 10.0 |
| Total purchase consideration | $160.5 | $0.1 | $160.6 |
Note 3 - Business Combinations (continued)
The following table summarizes the aggregate fair values of the assets acquired and liabilities assumed, as of the dates of the acquisition, for the 2022 Acquired Companies:
| (in millions) · Preliminary Fair Value at Acquisition Date · Measurement Period Adjustments · Adjusted Fair Value at Acquisition Date | ||||
|---|---|---|---|---|
| Cash and cash equivalents | $14.8 | $— | $14.8 | |
| Accounts receivable | 2.3 | — | 2.3 | |
| Prepaid expenses and other assets | 0.3 | 0.7 | 1.0 | |
| Intangible assets | 34.8 | — | 34.8 | |
| Accounts payable and other liabilities | (0.9) | (0.4) | (1.3) | |
| Unearned revenue | (6.8) | — | (6.8) | |
| Deferred tax liabilities | (6.5) | 2.9 | (3.6) | |
| Total identifiable net assets acquired | 38.0 | 3.2 | 41.2 | |
| Goodwill | 122.5 | (3.1) | 119.4 | |
| Total consideration | 160.5 | 0.1 | 160.6 | |
| Cash acquired | (14.8) | — | (14.8) | |
| Cash paid for acquisitions, net of cash acquired | $145.7 | $0.1 | $145.8 | |
| Cash paid (refunds received) for 2021 acquisitions in 2022 | (2.1) | |||
| Total cash paid for acquisitions in 2022 | $143.7 | |||
The excess of purchase consideration over the fair value of net tangible and intangible assets acquired was recorded as goodwill. The fair values assigned to tangible and identifiable intangible assets acquired and liabilities assumed are based on management’s estimates and assumptions. The fair values of assets acquired and liabilities assumed in the Comparably acquisition may be subject to change as additional information is received regarding working capital balances at the acquisition date, and the values of the identifiable intangible assets.
The following table sets forth the components of identifiable intangible assets acquired and the estimated useful lives as of the dates of acquisition:
| (in millions) | Preliminary Fair Value at Acquisition Date | Measurement Period Adjustments | Adjusted Fair Value at Acquisition Date | Weighted Average Useful Life |
|---|---|---|---|---|
| Existing Technology | $27.6 | $— | $27.6 | 5.8 years |
| Customer Relationships | 3.4 | — | 3.4 | 9.0 years |
| Trade name / Trademarks | 3.8 | — | 3.8 | 8.0 years |
| Total intangible assets | $34.8 | $— | $34.8 |
Developed technology represents the fair value of the technology portfolios acquired. The goodwill is primarily attributed to the expanded market opportunities when integrating technology with the Company’s technology and the assembled workforce. An immaterial portion of the goodwill acquired during the year ended December 31, 2022 is expected to be deductible for U.S. income tax purposes.
Pro forma information related to the acquisitions has not been presented as the impact was not material to the Company’s financial results.
Note 4 - Cash, Cash Equivalents, and Short-term Investments
Cash, cash equivalents, short-term investments consisted of the following as of December 31, 2024 and 2023, respectively:
| (in millions) | Amortized Cost | Unrealized Gains | Unrealized Losses | Estimated Fair Value |
|---|---|---|---|---|
| Cash | $125.5 | $— | $— | $125.5 |
| Cash equivalents: | ||||
| Certificates of deposit | $8.4 | $— | $— | $8.4 |
| Money market mutual funds | 6.0 | — | — | 6.0 |
| Total cash equivalents | $14.4 | $— | $— | $14.4 |
| Total cash and cash equivalents | $139.9 | $— | $— | $139.9 |
| (in millions) | Amortized Cost | Unrealized Gains | Unrealized Losses | Estimated Fair Value |
|---|---|---|---|---|
| Cash | $201.9 | $— | $— | $201.9 |
| Cash equivalents: | ||||
| Money market mutual funds | $245.2 | $— | $— | $245.2 |
| Total cash equivalents | $245.2 | $— | $— | $245.2 |
| Total cash and cash equivalents | $447.1 | $— | $— | $447.1 |
| Short-term investments: | ||||
| Corporate debt securities | $37.4 | $— | $— | $37.4 |
| Securities guaranteed by U.S. government | 26.7 | — | — | 26.7 |
| Other governmental securities | 18.1 | — | — | 18.1 |
| Total short-term investments | $82.2 | $— | $— | $82.2 |
| Total cash, cash equivalents, and short-term investments | $529.3 | $— | $— | $529.3 |
Refer to Note 9 - Fair Value for further information regarding the fair value of our financial instruments.
Gross unrealized losses on our available-for sale securities were immaterial at December 31, 2024 and 2023.
The following table summarizes the cost and estimated fair value of the securities classified as short-term investments based on stated effective maturities as of December 31, 2024 and 2023:
| December 31, 2024 | December 31, 2023 | |||
|---|---|---|---|---|
| (in millions) | Amortized Cost | Estimated Fair Value | Amortized Cost | Estimated Fair Value |
| Due within one year | $— | $— | $82.2 | $82.2 |
| Total | $— | $— | $82.2 | $82.2 |
Note 5 - Property and Equipment
The Company’s property and equipment consist of the following:
| December 31, | ||
|---|---|---|
| (in millions) | 2024 | 2023 |
| Computer equipment | $14.2 | $17.1 |
| Furniture and fixtures | 6.8 | 3.7 |
| Leasehold improvements | 47.2 | 13.1 |
| Internal use developed software | 122.3 | 84.0 |
| Construction in progress | 6.7 | 7.8 |
| Property and equipment, gross | $197.2 | $125.7 |
| Less: accumulated depreciation | (84.6) | (60.6) |
| Property and equipment, net | $112.6 | $65.1 |
Depreciation expense was $25.9 million, $19.6 million, and $17.6 million for the years ended December 31, 2024, 2023, and 2022, respectively. Depreciation expense for the year ended December 31, 2024 includes $2.0 million of accelerated depreciation associated with the Waltham Lease Restructuring (refer to Note 13 - Leases for further information).
Note 6 - Goodwill and Acquired Intangible Assets
Intangible assets, other than goodwill, consisted of the following as of December 31, 2024 and 2023, respectively:
| (in millions) | Gross Carrying Amount | Accumulated Amortization | Net | Weighted Average Amortization Period in Years |
|---|---|---|---|---|
| Intangible assets subject to amortization: | ||||
| Customer relationships | $288.1 | $(133.2) | $154.9 | 14.5 |
| Acquired technology | 331.3 | (246.6) | 84.7 | 6.3 |
| Brand portfolio | 11.5 | (8.3) | 3.2 | 7.8 |
| Total intangible assets subject to amortization | $630.9 | $(388.1) | $242.8 | |
| Intangible assets not subject to amortization: | ||||
| Pre-Acquisition ZI brand portfolio | $33.0 | $— | $33.0 | |
| Total intangible assets not subject to amortization | $33.0 | $— | $33.0 | |
| Total intangible assets | $663.9 | $(388.1) | $275.8 | |
Note 6 - Goodwill and Acquired Intangible Assets (continued)
| (in millions) | Gross Carrying Amount | Accumulated Amortization | Net | Weighted Average Amortization Period in Years |
|---|---|---|---|---|
| Intangible assets subject to amortization: | ||||
| Customer relationships | $287.6 | $(112.5) | $175.1 | 14.5 |
| Acquired technology | 330.8 | (208.4) | 122.4 | 6.3 |
| Brand portfolio | 11.5 | (7.4) | 4.1 | 7.9 |
| Total intangible assets subject to amortization | $629.9 | $(328.3) | $301.6 | |
| Intangible assets not subject to amortization: | ||||
| Pre-Acquisition ZI brand portfolio | $33.0 | $— | $33.0 | |
| Total intangible assets not subject to amortization | $33.0 | $— | $33.0 | |
| Total intangible assets | $662.9 | $(328.3) | $334.6 | |
Amortization expense was $59.8 million, $61.0 million, and $70.2 million for the years ended December 31, 2024, 2023, and 2022, respectively.
Future amortization expense for intangible assets as of December 31, 2024 is as follows:
| (in millions) | Estimated Amortization Expense |
|---|---|
| For years ended December 31, | |
| 2025 | $58.5 |
| 2026 | 48.6 |
| 2027 | 38.3 |
| 2028 | 21.9 |
| 2029 | 18.0 |
| Thereafter | 57.5 |
| Total amortization expense | $242.8 |
Goodwill was $1,692.7 million as of December 31, 2024, 2023 and 2022. There were no changes to the carrying amount of goodwill during the years presented. Based on the results of the Company’s impairment assessment, the Company didnot recognize any impairment of goodwill during the years ended December 31, 2024, 2023, and 2022.
Note 7 - Financing Arrangements
As of December 31, 2024 and 2023, the carrying values of the Company’s borrowings were as follows (in millions):
| December 31, | |||||||
|---|---|---|---|---|---|---|---|
| Instrument · Date of Issuance · Maturity Date · Elected Interest Rate · 2024 · 2023 | |||||||
| First Lien Term Loan | February 1, 2019 | February 28, 2030 | SOFR + 1.75% | $584.6 | $590.7 | ||
| First Lien Revolver | February 1, 2019 | February 28, 2028 | SOFR + 2.10% | — | — | ||
| Senior Notes | February 2, 2021 | February 1, 2029 | 3.875% | 643.1 | 641.7 | ||
| Total debt | $1,227.7 | $1,232.4 | |||||
| Less: current portion | (5.9) | (6.0) | |||||
| Total Long-term debt, net of current portion | $1,221.8 | $1,226.4 | |||||
First Lien Credit Agreement
Performance of obligations under the First Lien Credit Agreement is secured by substantially all the productive assets of the Company. The First Lien Credit Agreement contains a number of covenants that restrict, subject to certain exceptions, the Company’s ability to, among other things:
Incur additional indebtedness;
Create or incur liens;
Engage in certain fundamental changes, including mergers or consolidations;
Sell or transfer assets;
Pay dividends and distributions on our subsidiaries’ capital stock;
Make acquisitions, investments, loans or advances;
Engage in certain transactions with affiliates; and
Enter into negative pledge clauses and clauses restricting subsidiary distributions.
If the Company draws more than $87.5 million of the revolving credit loan, the revolving credit loan is subject to a springing financial covenant pursuant to which the consolidated first lien net leverage ratio must not exceed 5.00 to 1.00. The credit agreements also contain certain customary affirmative covenants and events of default, including a change of control. If an event of default occurs, the lenders under the credit agreements will be entitled to take various actions, including the acceleration of amounts due under the credit agreements and all actions permitted to be taken by a secured creditor.
First Lien Term Loan
In June 2024, we entered into an amendment to our existing First Lien Credit Agreement (the “Seventh Amendment”), pursuant to which the Company completed a repricing of its First Lien Term Loan Facility, which decreased the applicable rate for Base Rate loans from 1.25% to 0.75% and SOFR based loans from 2.25% to 1.75%. The Company recognized an immaterial loss in connection with the repricing during the year ended December 31, 2024 within Loss on debt modification and extinguishment on the Consolidated Statements of Operations. Under the terms of the Seventh Amendment, the Company is obligated to make principal payments in the amount of 0.25% of the aggregate outstanding amount as of the latest amendment.
Note 7 - Financing Arrangements (continued)
In December 2023, we entered into an amendment to our existing First Lien Credit Agreement (the "Sixth Amendment"), pursuant to which the Company completed a repricing of its First Lien Term Loan Facility, which decreased the applicable rate for Base Rate loans from 1.75% to 1.25% and SOFR based loans from 2.85% to 2.25%, and included the removal of the 0.1% credit spread adjustment.
In February 2023, we entered into an amendment to our existing First Lien Credit Agreement (the “Fifth Amendment”), pursuant to which the Company completed a repricing of its First Lien Term Loan Facility, which provided for an extension of the maturity date to February 28, 2030. The first lien term debt had a variable interest rate whereby the Company can elect to use a Base Rate or SOFR plus an applicable rate. Pursuant to the Fifth Amendment, the applicable rate decreased for Base Rate loans from 2.00% to 1.75% and from 3.10% to 2.85% for SOFR based loans.
The Company recognized an immaterial loss in connection with the repricing in the fiscal year ending December 31, 2023 within Loss on debt modification and extinguishment on the Consolidated Statements of Operations.
The effective interest rate on the first lien debt was 6.56% and 7.83% as of December 31, 2024 and 2023, respectively.
First Lien Revolving Credit Facility
Pursuant to the Fifth Amendment, the Company also extended the maturity date of $213.0 million of our $250.0 million existing commitments of the first lien revolving credit facility to February 28, 2028. Pursuant to the Sixth Amendment, $26.0 million of the non-extended commitments were extended to February 28, 2028. With respect to the $11.0 million commitments which were not extended as of December 31, 2024, the maturity date is November 2, 2025. Debt issuance costs were incurred in connection with the repricing of the revolving credit facility. These debt issuance costs are amortized into interest expense over the expected life of the arrangement. Unamortized debt issuance costs included in Deferred costs and other assets, net of current portion on our Consolidated Balance Sheets were immaterial as of December 31, 2024 and 2023.
The first lien revolving debt has a variable interest rate whereby the Company can elect to use a Base Rate or SOFR, plus an applicable rate. The applicable margin is 1.00% to 1.25% for Base Rate loans. The applicable margin for SOFR loans is 2.10% to 2.35%, which includes the credit spread adjustment of 0.1%, depending on the Company’s Consolidated First Lien Net Leverage Ratio.
The expected future principal payments for all borrowings as of December 31, 2024 is as follows:
| (in millions) | Contractual Maturity |
|---|---|
| 2025 | $5.9 |
| 2026 | 5.9 |
| 2027 | 5.9 |
| 2028 | 5.9 |
| 2029 | 655.9 |
| Thereafter | 558.6 |
| Total principal payments | $1,238.1 |
| Unamortized debt issuance costs | (10.4) |
| Total debt | $1,227.7 |
Note 8 - Derivatives and Hedging Activities
Interest Rate Hedges
We are exposed to risks from changes in interest rates related to the first lien term loan (See Note 7 - Financing Arrangements). The Company uses derivative financial instruments, specifically, interest rate swap contracts, in order to manage its exposure to interest rate movements. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. Our primary objective in holding derivatives is to reduce the volatility of cash flows associated with changes in interest rates. The Company does not enter into derivative transactions for speculative or trading purposes.
In the second quarter of 2022, two interest rate swap contracts in the notional amount of $350.0 million matured. Interest rate swaps in the notional amount of $500.0 million became effective in April 2022.
In the third quarter of 2022, the Company sold $400.0 million of the notional amount of the interest rate cap contract which was not designated as an accounting hedge. We recognized a gain of $3.0 million, partially offset by the derecognition of $2.5 million of derivative assets, resulting from this sale within Interest expense, net on our Consolidated Statements of Operations.
In the fourth quarter of 2022, the Company transitionedtwo interest rate swap contracts andone interest cap contract from LIBOR to SOFR by terminating the original transactions and simultaneously entering into new derivatives. The terms of the new derivatives were unchanged except for the index. The Company elected optional expedients to allow for this transition without any interruptions to the hedge accounting.
During the second quarter of 2024, the Company’s interest rate cap contract matured. As December 31, 2024, the Company had the following outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk (in millions):
| Interest Rate Derivatives(Level 2) | Number of Instruments | Notional Aggregate Principal Amount | Interest Cap / Swap Rate | Maturity Date |
|---|---|---|---|---|
| Interest rate swap contracts | Two | 500.0 | 0.370% | January 30, 2026 |
The derivative interest rate swaps are designated and qualify as cash flow hedges. Consequently, the change in the estimated fair value of the effective portion of the derivative is recognized in Accumulated other comprehensive income on our Consolidated Balance Sheets and reclassified to Interest expense, net, when the underlying transaction has an impact on earnings. The Company expects to recognize approximately $18 million of net pre-tax gains from accumulated other comprehensive income as a reduction of interest expense in the next twelve months associated with its interest rate swap.
Refer to the Company’s Consolidated Statements of Comprehensive Income for amounts reclassified from Accumulated other comprehensive income into earnings related to the Company’s derivative instruments designated as cash flow hedging instruments for each of the reporting periods.
Foreign Currency Hedges
We are exposed to changes in currency exchange rates, primarily relating to changes in the Israeli Shekel. Consequently, from time to time, we may use foreign exchange forward contracts or other financial instruments to manage our exposure to foreign exchange rate movements. Our primary objective in holding derivatives is to reduce the volatility of cash flows associated with changes in foreign exchange rates. We do not enter into derivative transactions for speculative or trading purposes.
Note 8 - Derivatives and Hedging Activities (continued)
During the year ended December 31, 2024, the Company actively participated in foreign currency forward contracts with a cumulative notional amount of $31.9 million, all of which were settled in 2024. These transactions resulted in an immaterial gain which offset lower operating expenses due to favorable changes in the foreign currency.
During the year ended December 31, 2023, the Company actively participated in foreign currency forward contracts with a cumulative notional amount of $26.2 million, all of which were settled in 2023. These transactions resulted in an immaterial loss which offset lower operating expenses due to favorable changes in the foreign currency.
The derivative foreign currency forward contracts are designated and qualify as cash flow hedges. Consequently, the change in the estimated fair value of the effective portion of the derivative is recognized in Accumulated other comprehensive income on our Consolidated Balance Sheets and reclassified to revenue or operating expenses depending on the nature of the underlying transaction, when the underlying transaction has an impact on earnings. Impacts on Cash and cash equivalents are presented as operating cash flows on our Consolidated Statements of Cash Flows in the period contracts are settled.
The following table summarizes the fair value and presentation on our Consolidated Balance Sheets for derivatives as of December 31, 2024 and 2023 (in millions):
| Fair Value of Derivative Instruments | ||||
|---|---|---|---|---|
| December 31, 2024 | December 31, 2023 | |||
| Instrument | Derivative Assets | Derivative Liabilities | Derivative Assets | Derivative Liabilities |
| Derivatives designated as hedging instruments: | ||||
| Interest rate cap contract(1) | $— | $— | $0.6 | $— |
| Interest rate swap contracts(1) | 18.5 | — | 21.2 | — |
| Interest rate swap contracts(2) | 1.4 | — | 15.0 | — |
| Total designated derivative fair value | $19.9 | $— | $36.8 | $— |
(1)Included in Prepaid expenses and other current assets on our Consolidated Balance Sheets.
(2)Included in Deferred costs and other assets, net of current portion on our Consolidated Balance Sheets.
Refer to the Company’s Consolidated Statements of Comprehensive Income for amounts reclassified from Accumulated other comprehensive income into earnings related to the Company’s Derivative Instruments designated as cash flow hedging instruments for each of the reporting periods.
Note 9 - Fair Value
The Company's financial instruments consist principally of cash and cash equivalents, short-term investments, prepaid expenses and other current assets, accounts receivable, and accounts payable, accrued expenses, and long-term debt. The carrying value of cash and cash equivalents, prepaid expenses and other current assets, accounts receivable, accounts payable, and accrued expenses approximate fair value, primarily due to short maturities. We classify our certificates of deposits and money market mutual funds as Level 1 within the fair value hierarchy. We classify our corporate debt securities, securities guaranteed by the U.S. government and other governmental securities as Level 2 within the fair value hierarchy. The fair value of our first term lien debt and Senior Notes was $584.0 million and $585.0 million as of December 31, 2024, and $595.5 million and $588.3 million as of December 31, 2023, respectively, based on observable market prices in less active markets and categorized as Level 2 within the fair value measurement framework.
Note 9 - Fair Value (continued)
The Company has elected to use the income approach to value the interest rate derivatives using observable Level 2 market expectations at measurement date and standard valuation techniques to convert future amounts to a single present amount (discounted) reflecting current market expectations about those future amounts. Level 2 inputs for the derivative valuations are limited to quoted prices for similar assets or liabilities in active markets (specifically futures contracts) and inputs other than quoted prices that are observable for the asset or liability (specifically SOFR cash and swap rates, implied volatility for options, caps and floors, basis swap adjustments, overnight indexed swap (“OIS”) short term rates and OIS swap rates, when applicable, and credit risk at commonly quoted intervals). Mid-market pricing is used as a practical expedient for most fair value measurements. Key inputs, including the cash rates for very short-term, futures rates and swap rates beyond the derivative maturity, are interpolated to provide spot rates at resets specified by each derivative (reset rates are then further adjusted by the basis swap, if necessary). Derivatives are discounted to present value at the measurement date at SOFR rates unless they are fully collateralized. Fully collateralized derivatives are discounted to present value at the measurement date at OIS rates (short-term OIS rates and long-term OIS swap rates).
Inputs are collected from SuperDerivatives, an independent third-party derivative pricing data provider, as of the close on the last day of the period. The valuation of the interest rate swaps also take into consideration estimates of our own, as well as our counterparty’s, risk of non-performance under the contract.
We estimate the value of other long-lived assets that are recorded at fair value on a non-recurring basis based on a market valuation approach. We use prices and other relevant information generated primarily by recent market transactions involving similar or comparable assets, as well as our historical experience in divestitures, acquisitions and real estate transactions. Additionally, we may use a cost valuation approach to value long-lived assets when a market valuation approach is unavailable. Under this approach, we determine the cost to replace the service capacity of an asset, adjusted for physical and economic obsolescence. When available, we use valuation inputs from independent valuation experts, such as real estate appraisers and brokers, to corroborate our estimates of fair value. Real estate appraisers’ and brokers’ valuations are typically developed using one or more valuation techniques including market, income, and replacement cost approaches. Because these valuations contain unobservable inputs, we classify the measurement of fair value of long-lived assets as Level 3.
The fair value of our financial assets was determined using the following inputs (in millions):
| Fair Value at December 31, 2024 | Level 1 | Level 2 | Level 3 |
|---|---|---|---|
| Measured on a recurring basis: | |||
| Assets: | |||
| Cash equivalents: | |||
| Certificates of deposit | $8.4 | $— | $— |
| Money market mutual funds | 6.0 | — | — |
| Prepaid expenses and other current assets: | |||
| Interest rate swap contracts | $— | $18.5 | $— |
| Deferred costs and other assets, net of current portion: | |||
| Interest rate swap contracts | $— | $1.4 | $— |
| Total | $14.4 | $19.9 | $— |
| Measured on a non-recurring basis: | |||
| Impaired lease-related assets (1) | $— | $— | $31.5 |
| Total | $— | $— | $31.5 |
(1)Consists of right-of-use lease assets recorded at fair value pursuant to impairment charges that occurred during the second and third quarter of 2024. Refer to Note 13 - Leases for further information regarding the impairment of lease-related assets.
Note 9 - Fair Value (continued)
| Fair Value at December 31, 2023 | Level 1 | Level 2 | Level 3 |
|---|---|---|---|
| Measured on a recurring basis: | |||
| Assets: | |||
| Cash equivalents: | |||
| Money market mutual funds | $245.2 | $— | $— |
| Short-term investments: | |||
| Corporate debt securities | $— | $37.4 | $— |
| Securities guaranteed by U.S. government | — | 26.7 | — |
| Other governmental securities | — | 18.1 | — |
| Prepaid expenses and other current assets: | |||
| Interest rate cap contract | $— | $0.6 | $— |
| Interest rate swap contracts | — | 21.2 | — |
| Deferred costs and other assets, net of current portion: | |||
| Interest rate swap contracts | — | 15.0 | — |
| Total | $245.2 | $119.0 | $— |
| Measured on a non-recurring basis: | |||
| Impaired lease-related assets | $— | $— | $13.6 |
| Total | $— | $— | $13.6 |
There were no transfers between fair value measurement levels during the years ended December 31, 2024 and 2023.
Refer to Note 4 - Cash, Cash Equivalents, and Short-term Investments for further information regarding the fair value of our financial instruments. Refer to Note 8 - Derivatives and Hedging Activities for further information regarding the fair value of our derivative instruments.
Note 10 - Commitments and Contingencies
Non-cancelable purchase obligations
As of December 31, 2024, our outstanding non-cancelable purchase obligations, mainly related to third-party cloud hosting and SaaS arrangements, were as follows (in millions):
| Fiscal Period | Amount |
|---|---|
| 2025 | $45.5 |
| 2026 | 44.3 |
| 2027 | 15.1 |
| 2028 | — |
| 2029 | — |
| Thereafter | — |
| Total | $104.9 |
For information regarding financing-related obligations, refer to Note 7 - Financing Arrangements. For information regarding lease-related obligations, refer to Note 13 - Leases.
Note 10 - Commitments and Contingencies (continued)
Contingent earnout payments
In connection with the acquisition of Dogpatch Advisors, LLC in April 2022, the Company could be required to issue remaining equity awards up to $0.6 million. As of December 31, 2024, the Company has paid $1.9 million. Refer to Note 3 - Business Combinations for additional information.
Deferred acquisition-related payments
In connection with the acquisition of Insent, the Company paid $2.0 million during the year ended December 31, 2024, of which $0.7 million represents deferred consideration.
Legal matters
We are subject to various legal proceedings, claims, and governmental inspections, audits, or investigations that arise in the ordinary course of our business. There are inherent uncertainties in these matters, some of which are beyond management’s control, making the ultimate outcomes difficult to predict. Moreover, management’s views and estimates related to these matters may change in the future, as new events and circumstances arise and the matters continue to develop. Based on the information known by the Company as of the date of this filing, except where otherwise indicated, it is not possible to provide an estimated amount of any loss or range of loss that may occur with respect to these matters, including without limitation the matters described below.
ZoomInfo Publicity Litigation
On April 15, 2021, a putative class action lawsuit was filed against ZoomInfo Technologies LLC in the United States District Court for the Northern District of Illinois (Eastern Division) alleging ZoomInfo’s use of Illinois residents’ names in public-facing web pages violates the Illinois Right of Publicity Act, and seeking statutory, compensatory and punitive damages, costs, and attorneys’ fees. Additionally, on September 30, 2021, a putative class action lawsuit was filed against ZoomInfo Technologies Inc. in the United States District Court for the Western District of Washington alleging ZoomInfo’s use of California residents’ names in public-facing web pages violates California statutory and common law regarding the right of publicity as well as misappropriation, and seeking compensatory and punitive damages, restitution, injunctive relief, declaratory relief, costs, and attorneys’ fees. On November 21, 2024, the Company entered into a settlement to resolve the Illinois class action, the California class action and similar, unfiled claims in the states of Indiana and Nevada (the “Class Actions”). The settlement is not an admission of fault or wrongdoing by ZoomInfo. During the year ended December 31, 2024, the Company incurred total charges of $30.1 million, which is substantially comprised of the settlement amount, all of which has been paid as of December 31, 2024, and other legal costs.
On September 5, 2024, a putative class action lawsuit was filed against ZoomInfo Technologies LLC in the U.S. District Court for the Western District of Washington alleging ZoomInfo Technologies LLC’s use of individuals’ names in public-facing web pages violates the Washington Personality Rights Act, and seeking statutory, compensatory and punitive damages, costs, and attorneys’ fees. The Company intends to vigorously defend against this lawsuit.
Note 10 - Commitments and Contingencies (continued)
Datanyze Publicity Litigation
On February 10, 2023, a putative class action lawsuit was filed against Datanyze, LLC, one of the Company’s subsidiaries, in the Circuit Court of Cook County, Illinois alleging Datanyze’s use of Illinois residents’ names in a free trial violates the Illinois Right of Publicity Act, and seeking statutory, compensatory and punitive damages, costs, and attorneys’ fees. The case was removed to the United States District Court for the Northern District of Illinois (Eastern Division). On October 23, 2024, a putative class action lawsuit was filed against Datanyze, LLC in the Northern District of California, San Francisco Division, alleging Datanyze’s use of California, Nevada, Indiana, and Alabama residents’ names in a free trial violates statutory rights-of-publicity in the respective states, and seeking statutory, compensatory and punitive damages, costs, and attorneys’ fees. On February 12, 2025, Datanyze entered into a binding term sheet with the plaintiffs in both of these class actions, to resolve these class actions for an immaterial amount. As contemplated in the parties’ agreement, the parties stipulated to the dismissal of both federal actions. The claims were re-filed as a single case in the Circuit Court of DuPage County, Illinois solely for purposes of facilitating settlement.
On March 8, 2023, a putative class action lawsuit was filed against Datanyze, LLC in the United States District Court for the Northern District of Ohio alleging Datanyze's use of Ohio residents names in a free trial violates the Ohio Right of Publicity Statute, and seeking statutory damages, costs, and attorneys’ fees. On November 17, 2023, the court dismissed the plaintiffs’ claims with prejudice and on January 14, 2025, the United States Court of Appeals for the Sixth Circuit affirmed the district court’s dismissal. To the extent plaintiffs seek any further review of these orders, the Company intends to continue to vigorously defend against this lawsuit.
Securities Litigation
On September 4, 2024, a putative class action lawsuit was filed against ZoomInfo Technologies Inc. and certain of its current and former officers and affiliates in the U.S. District Court for the Western District of Washington. The suit, brought on behalf of purchasers of Company common stock between November 10, 2020, and August 5, 2024, alleges that the defendants made false and/or misleading statements related to the Company’s business, operations, and prospects, including in respect of the effects of the COVID-19 pandemic on the Company’s performance, in violation of §10(b) and §20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder. The complaint seeks, among other relief, unspecified compensatory damages, equitable relief, and costs and expenses. The Company intends to vigorously defend against this lawsuit.
On December 12, 2024, certain of the Company’s current and former directors and officers were named as defendants in a derivative shareholder lawsuit (in which the Company is a nominal defendant) filed in the United States District Court for the Western District of Washington. A second derivative action was filed on February 4, 2025 in the United States District Court for the Western District of Washington. The factual allegations in the derivative cases mirror the securities case described above. The complaints assert violations of the United States securities laws and state fiduciary duty laws, in addition to common law claims involving unjust enrichment, abuse of control, gross mismanagement, and waste of corporate assets. The derivative cases seek, among other things, unspecified compensatory damages on behalf of the Company arising out of the individual defendants’ alleged wrongful conduct. The first-filed derivative action is currently stayed pending further developments in the securities action described above. The parties have requested that the court stay the second-filed derivative action and consolidate it with the first-filed action.
Note 11 - Stockholders' Equity
In March 2023, the Board authorized a program to repurchase the Company’s common stock (the “Share Repurchase Program”). The total authorizations in 2023 and 2024 were $600.0 million and $500.0 million, respectively, of which $137.6 million remained available and authorized for repurchases as of December 31, 2024. Shares of common stock may be repurchased under the Share Repurchase Program from time to time through open market purchases, block trades, private transactions or accelerated or other structured share repurchase programs. The extent to which the Company repurchases shares of common stock, and the timing of such purchases, will depend upon a variety of factors, including market conditions, regulatory requirements and other corporate considerations, as determined by the Company. The Share Repurchase Program may be suspended or discontinued at any time.
During the year ended December 31, 2024, the Company repurchased and subsequently retired 46,801,742 shares of common stock at an average price of $12.01, for an aggregate $562.3 million. During the year ended December 31, 2023, the Company repurchased and subsequently retired 22,627,664 shares of common stock at an average price of $17.68, for an aggregate $400.1 million.
In August 2024, the Company entered into an accelerated share repurchase agreement (the “ASR Transaction”) with a financial institution. The Company settled the ASR Transaction in September 2024 resulting in a total repurchase and subsequent retirement of 12,431,216 shares of the Company’s common stock for $125.0 million at an average price of $10.06 per share, recorded as a reduction of Additional paid-in capital. The total number of shares delivered was determined at the settlement date based on the volume weighted average price, less an agreed upon discount. The ASR Transaction was completed under the Company’s previously announced Share Repurchase Program.
The Inflation Reduction Act of 2022, enacted into law on August 16, 2022, imposed a nondeductible 1% excise tax on the net value of certain stock repurchases made after December 31, 2022. The Company calculates excise tax due based on the year-to-date amount repurchased in excess of the fair market value of shares issued and is included within Accrued expenses and other current liabilities on our Consolidated Balance Sheets. During the year ended December 31, 2024 and 2023, the Company recorded the associated excise taxes of $5.1 million and $3.3 million, respectively. Excise taxes associated with these share repurchases are presented within Repurchase of common stock on our Consolidated Statements of Changes in Stockholders' Equity, as a reduction to Additional paid-in capital. During the years ended December 31, 2024 and 2023, the Company made excise tax payments of $3.3 million andzero, respectively.
Common Stock Rights
Our authorized capital stock consists of 3,300,000,000 shares of common stock and 200,000,000 shares of preferred stock, par value $0.01 per share. No shares of preferred stock have been issued or are currently outstanding.
Voting rights
Holders of common stock will vote as a single class and are entitled toone vote per share on all matters on which stockholders of ZoomInfo Technologies Inc. are entitled to vote generally, including the election or removal of directors. The holders of our common stock do not have cumulative voting rights in the election of directors.
Preemptive or similar rights
Holders of shares of our common stock do not have preemptive, subscription, redemption or conversion rights. There are no redemption or sinking fund provisions applicable to the common stock.
Note 11 - Stockholders' Equity (continued)
Dividends and distributions
Holders of common stock are entitled to receive dividends at the same rate, when, as and if declared by our Board of Directors out of funds legally available therefor, subject to any statutory or contractual restrictions on the payment of dividends and to the rights of the holders of one or more outstanding series of our preferred stock. To date, no dividends have been declared or paid by us.
Upon our liquidation, dissolution, or winding up, subject to the rights of holders of one or more outstanding series of preferred stock having liquidation preferences, the holders of shares of our common stock are entitled to receive pro rata our remaining assets available for distribution.
Note 12 - Earnings Per Share
The following tables set forth the computation of basic and diluted net income per share of common stock:
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Basic net income per share attributable to common stockholders | |||
| Numerator: | |||
| Net income | $29.1 | $107.3 | $63.2 |
| Denominator: | |||
| Weighted average number of shares of common stock outstanding | 361,953,130 | 396,987,015 | 401,490,459 |
| Basic net income per share attributable to common stockholders | $0.08 | $0.27 | $0.16 |
| Diluted net income per share attributable to common stockholders | |||
| Numerator: | |||
| Net income | $29.1 | $107.3 | $63.2 |
| Denominator: | |||
| Number of shares used in basic computation | 361,953,130 | 396,987,015 | 401,490,459 |
| Add: weighted-average effect of dilutive securities exchangeable for common stock: | |||
| Restricted stock awards | 62,996 | 323,619 | 1,641,544 |
| Exercise of common stock options | — | 25,630 | 187,578 |
| Employee Stock Purchase Plan | 173,018 | 144,167 | 72,877 |
| Weighted average shares of common stock outstanding used to calculate diluted net income per share | 362,189,144 | 397,480,431 | 403,392,458 |
| Diluted net income per share attributable to common stockholders | $0.08 | $0.27 | $0.16 |
The following weighted-average potentially dilutive securities were evaluated under the treasury stock method for potentially dilutive effects and have been excluded from diluted net income per share in the periods presented due to their anti-dilutive effect:
| December 31, 2024 | December 31, 2023 | December 31, 2022 | |
|---|---|---|---|
| Restricted stock units | 15,341,169 | 13,179,013 | 8,198,069 |
| Exercise of common stock options | 162,484 | — | — |
| Total anti-dilutive securities | 15,503,653 | 13,179,013 | 8,198,069 |
Note 13 - Leases
The Company has operating leases for corporate offices under non-cancelable agreements with various expiration dates. Our leases do not have significant rent escalation, holidays, concessions, material residual value guarantees, material restrictive covenants, or contingent rent provisions. Our leases include both lease (e.g., fixed payments including rent, taxes, and insurance costs) and non-lease components (e.g., common-area or other maintenance costs) which are accounted for as a single lease component. In addition, we have elected the practical expedient to exclude short-term leases, which have an original lease term of one year or less, from our right-of-use assets and lease liabilities as well as the package of practical expedients relating to the adoption of ASC 842.
The Company subleasestwo offices. The subleases have remaining lease terms of less than seven years. Sublease income, which is recorded as a reduction of rent expense and allocated to the appropriate financial statement line items to arrive at Income from operationson our Consolidated Statements of Operations, was immaterial for the years ended December 31, 2024, 2023, and 2022.
The right-of-use asset and lease liability balances as of December 31, 2024 and 2023 were as follows:
| December 31, | ||
|---|---|---|
| (in millions) | 2024 | 2023 |
| Assets | ||
| Operating lease right-of-use assets, net | $90.9 | $80.7 |
| Liabilities | ||
| Current portion of operating lease liabilities | $9.9 | $11.2 |
| Operating lease liabilities, net of current portion | 151.2 | 89.9 |
| Total lease liabilities | $161.1 | $101.1 |
Rent expense was $64.9 million, inclusive of $38.8 million related to the Waltham Lease Restructuring, $17.7 million, and $13.4 million for the years ended December 31, 2024, 2023, and 2022, respectively.
Other information related to leases was as follows:
| December 31, | |||
|---|---|---|---|
| (in millions) | 2024 | 2023 | 2022 |
| Supplemental Cash Flow Information | |||
| Cash paid for amounts included in the measurement of operating lease liabilities | $63.6 | $12.3 | $12.4 |
| Cash received for tenant incentive reimbursement | 13.2 | 0.1 | 5.0 |
| Lease liabilities arising from obtaining right-of-use assets | |||
| From new and existing lease agreements and modifications | $134.3 | $31.1 | $11.3 |
| As of December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Weighted average remaining lease term (in years) | 13.0 | 10.3 |
| Weighted average discount rate | 7.5% | 6.2% |
The table below reconciles the undiscounted future minimum lease payments under non-cancelable leases to the total lease liabilities recognized as of December 31, 2024 (in millions):
| Year Ending December 31, | Operating Leases |
|---|---|
| 2025 | $(16.6) |
| 2026 | 16.1 |
| 2027 | 24.5 |
| 2028 | 25.9 |
| 2029 | 26.3 |
| Thereafter | 226.9 |
| Total future minimum lease payments | $303.1 |
| Less: Effects of discounting | 142.0 |
| Total lease liabilities | $161.1 |
The table above does not include any legally binding minimum lease payments for leases signed but not yet commenced. Included in the undiscounted future minimum lease payments for the years ended December 31, 2025, and 2026 are future tenant improvement allowance reimbursements related to our Ra’anana, Israel and Vancouver, Washington leases.
Expense associated with short-term leases and variable lease costs were immaterial for the years ended December 31, 2024, 2023, and 2022. The expense related to short-term leases reasonably reflected our short-term lease commitments.
Undiscounted lease payments under all leases executed and not yet commenced are anticipated to be $62.1 million which relate to a lease expected to commence in 2025. These payments are not included in the tabular disclosure of undiscounted future minimum lease payments under non-cancelable leases above.
Recent Leasing Activity
Relating to our office space in Waltham, Massachusetts, the third and fourth phases of the lease commenced in April 2024 which, collectively, resulted in additional lease liabilities arising from obtaining right-of-use assets of $8.5 million. We recognized impairment charges of $4.3 million to reduce the carrying value of the associated right-of-use assets. Additionally, we recognized impairment charges of $4.8 million to reduce the carrying value of the right-of-use asset associated with the second phase of the lease. These charges are presented within General and administrative on the Consolidated Statements of Operations and relate to certain spaces which were intended to sublease. During the second quarter of 2024, the Company committed to the cease-use of all phases except for the first and second phases. As a result, we incurred lease abandonment charges of $4.1 million for the vacated spaces. These charges were allocated among the appropriate financial statement line items on the Consolidated Statements of Operations.
Subsequently, in July 2024, the Company executed an agreement to restructure its existing lease commitments (“Waltham Lease Restructuring”). Pursuant to the agreement, the Company made a payment of $59.1 million. In accordance with ASC 842, the Company remeasured its lease liabilities using the revised lease payments under the modified agreement, which included the $59.1 million, and reallocated the remaining minimum lease payments in the contract to the remaining lease components. The reallocated portion of the minimum lease payments for the final phase, which had not yet commenced, of $13.1 million was recorded as a prepaid. These charges will be recognized in rent expense over the remaining lease terms which originally ranged from December 31, 2024 to December 31, 2025. The increase in our operating lease right-of-use assets resulting from the $59.1 million payment, combined with the shortened lease term, increased the amortization of those assets. Refer to the discussion below regarding the subsequent amendment to the agreement in November 2024. The Company also recorded a gain of $1.7 million as a result of the modification, which is presented within General and administrative on the Consolidated Statements of Operations for the year ended December 31, 2024. Additionally, the fifth phase of the lease commenced in the third quarter of 2024, resulting in additional lease liabilities arising from obtaining right-of-use assets of $16.1 million.
Also in July 2024, the Company executed a new lease agreement for separate office space in Waltham, Massachusetts with the same landlord, with rent payments expected to commence in the fourth quarter of 2025. The lease will terminate on December 31, 2038. The lease is subject to fixed-rate rent escalations and provides for $7.6 million in tenant improvements and the option to extend the lease fortwo terms offive years each. The Company determined that it is the accounting owner of all tenant improvements. As the commencement of the lease is expected to occur in the future, the Company has not recorded an operating lease right-of-use asset or lease liability for this space as of December 31, 2024. Undiscounted lease payments are anticipated to be $62.1 million, and are not included in the tabular disclosure of undiscounted future minimum lease payments under non-cancelable leases above.
In November 2024, the Company executed an amendment to the Waltham Lease Restructuring agreement (“Amended Waltham Lease Restructuring”). Pursuant to the amendment, the Company agreed to lease separate office space in Waltham, Massachusetts with the same landlord in place of certain remaining lease components of the existing space, whereby the existing space terminated immediately upon execution. The Company derecognized right-of-use assets of $17.6 million and operating lease liabilities of $1.4 million associated with these components, as well as $13.1 million in prepaid rent and $0.8 million in initial direct costs resulting from the accounting treatment of the termination fee to a leased space which had not commenced as of the execution date. Additionally, in accordance with ASC 842, the resulting loss was partially offset by $1.6 million due to the difference between the present value of the lease payments and the market rent. This resulted in a net loss of $28.3 million which was allocated to the appropriate financial statement line items on the Consolidated Statements of Operations. The remaining components which were not impacted by the amendment terminated on December 31, 2024 under the terms of the Amended Waltham Lease Restructuring (refer to the separate amendment agreement subsequently signed below). Related to the Amended Waltham Lease Restructuring, the Company expects rent payments to commence in the first quarter of 2025. The lease ends on December 31, 2025, and undiscounted lease payments are $1.5 million.
Additionally, in November 2024, the Company executed a second amendment to the Waltham Lease Restructuring agreement to extend the term for a portion of the remaining components, which were set to terminate on December 31, 2024, by three months and is set to terminate on March 31, 2025. The Company is not obligated to make any additional lease payments as a result of the extension.
Relating to our new corporate headquarters in Vancouver, Washington, the sixth floor of the lease commenced in March 2024. The commencement of the floor resulted in additional lease liabilities arising from obtaining right-of-use assets of $27.5 million. The seventh, eighth, and ninth floors of the lease commenced in April, May, and June, respectively. The commencement of these floors resulted in additional lease liabilities arising from obtaining right-of-use assets of $59.2 million. The tenth floor and lobby of the lease commenced in September, resulting in additional lease liabilities arising from obtaining right-of-use assets of $15.4 million. The amenities portion of the lease commenced in October, resulting in additional lease liabilities arising from obtaining right-of-use assets of $4.4 million. During the year ended December 31, 2024, we recognized impairment charges of $37.9 million to reduce the carrying value of the right-of-use assets associated with certain spaces of the leased premises which were intended to sublease. These charges are presented within General and administrative on the Consolidated Statements of Operations.
Relating to our office space in Ra’anana, Israel, which commenced during the third quarter of 2023, we recognized additional impairment charges of $5.9 million during the year ended December 31, 2024 related to certain spaces of the leased premises which were intended to sublease. These charges are presented within General and administrative on the Consolidated Statements of Operations.
Note 14 - Equity-based Compensation
2020 Omnibus Incentive Plan- On May 26, 2020, the Board adopted the Omnibus Plan. The Omnibus Plan provides for potential grants of the following awards with respect to shares of the Company’s common stock or securities valued by reference to, or otherwise determined by reference to or based on, shares of common stock: (i) incentive stock options qualified as such under U.S. federal income tax laws; (ii) non-qualified stock options or any other form of stock options; (iii) stock appreciation rights; (iv) restricted stock; (v) restricted stock units; (vi) interests in a limited liability company that is a subsidiary of the Company, and (vii) other equity-based and cash-based incentive awards as determined by the compensation committee of the Board or any properly delegated subcommittee.
The maximum aggregate number of shares of common stock that could be issued pursuant to awards under the Omnibus Plan was 18,650,000 shares (including other securities which have been issued under the plan and were converted into awards based on shares of common stock) (the “Plan Share Reserve”). The Omnibus Plan also contains a provision that will add an additional number of shares of common stock to the Plan Share Reserve on the first day of each year starting with January 1, 2021, equal to the lesser of (i) the positive difference between (x)5% of the number of shares of common stock outstanding on the last day of the immediately preceding year, and (y) the Plan Share Reserve on the last day of the immediately preceding year, and (ii) a lower number of shares of common stock as may be determined by the Board. As of December 31, 2024, the number of shares remaining available for future issuance under the Omnibus Incentive Plan was 11,517,998.
The Company currently has equity-based compensation awards outstanding as follows: restricted stock units, and common stock options. In addition, the Company recognizes equity-based compensation expense from awards granted to employees as further described below under HSKB Phantom Units.
Except where indicated otherwise, the equity-based compensation awards described below are subject to time-based service requirements. For all grants issued, the service vesting condition is generally four years with 25% vesting on theone-year anniversary of the grant date of the award and 6.25% vesting quarterly thereafter; orthree years with 33% vesting on theone-year anniversary of the grant date of the award and 8.375% vesting quarterly thereafter.
During the second quarter of 2024, the Company issued performance-based RSUs (“PRSUs”) which will vest in annual tranches over athree-year service period. Total PRSUs earned for grants made in 2024 may vary between 0% and 150% of the PRSUs granted based on the attainment of company specific-performance targets during the related performance period and continued service. All of the PRSUs earned will be settled through the issuance of an equivalent number of shares of the Company’s common stock based on the payout level achieved.
During the year ended December 31, 2023, the Company issued PRSUs, which were recommended by the Compensation Committee of the Board and approved by the full Board. The service vesting condition for one of the issued awards isone year. Each of the remaining PRSUs will vest in annual tranches over athree-year service period. Total PRSUs earned for grants made in 2023 may vary between 0% and 200% of the PRSUs granted based on the attainment of company-specific performance targets during the related performance period and continued service. In 2024, the Compensation committee elected to cancel the PRSUs granted in 2023.
During the second quarter of 2024, the Company issued market-based RSUs, which were approved by the Board. These awards will vest over the performance period which commenced on June 20, 2024, and will conclude on April 1, 2027. The vesting is based on the attainment of an average 30-day closing price of the applicable stock price threshold of the Company’s common stock at any time during the performance period and subject to continuous employment through the vesting dates.
| Tranche | Company Stock Price Target | Number of Eligible Market-Based RSUs | Satisfaction of Minimum Service Requirement |
|---|---|---|---|
| 1 | $15.11 | 110,295 | Service through and including January 1, 2025 |
| 2 | 17.61 | 110,294 | Service through and including October 1, 2025 |
| 3 | 20.11 | 110,294 | Service through and including July 1, 2026 |
| 4 | 22.61 | 110,294 | Service through and including April 1, 2027 |
Certain additional grants have other vesting periods approved by the Compensation Committee of the Board.
Restricted Stock Units
Restricted stock unit activity was as follows during the periods indicated:
| Year Ended December 31, 2024 · Year Ended December 31, 2023 · Year Ended December 31, 2022 | ||||
|---|---|---|---|---|
| Restricted Stock Units | Weighted Average Grant Date Fair Value | Restricted Stock Units | Restricted Stock Units | |
| Unvested at beginning of period | 12,636,460 | $29.23 | 10,377,568 | 4,853,795 |
| Granted | 11,205,269 | 13.28 | 8,731,967 | 8,678,522 |
| Granted - performance-based | 272,797 | 13.01 | 509,824 | 147,445 |
| Granted - market-based | 441,177 | 4.28 | — | — |
| Vested | (5,295,543) | 29.77 | (4,292,910) | (1,265,449) |
| Forfeited | (4,040,141) | 25.14 | (2,689,989) | (2,036,745) |
| Unvested at end of period | 15,220,019 | 17.37 | 12,636,460 | 10,377,568 |
Restricted Stock
Restricted stock activity was as follows during the periods indicated:
| Year Ended December 31, 2024 · Year Ended December 31, 2023 · Year Ended December 31, 2022 | ||||
|---|---|---|---|---|
| Restricted stock | Weighted Average Grant Date Fair Value | Restricted stock | Restricted stock | |
| Unvested at beginning of period | 347,976 | $34.55 | 858,560 | 3,525,373 |
| Vested | (327,564) | 35.93 | (499,607) | (2,387,766) |
| Forfeited | (20,412) | 12.39 | (10,977) | (279,047) |
| Unvested at end of period | — | — | 347,976 | 858,560 |
Common Stock Options
Common stock options activity was as follows during the period indicated:
| Year Ended December 31, 2024 · Year Ended December 31, 2023 · Year Ended December 31, 2022 | ||||
|---|---|---|---|---|
| Options | Weighted Average Exercise Price | Options | Options | |
| Outstanding at beginning of period | 279,553 | $21.00 | 323,002 | 417,085 |
| Exercised | — | — | (18,448) | (63,193) |
| Expired | (51,494) | 21.00 | (20,715) | (7,950) |
| Forfeited | — | — | (4,286) | (22,940) |
| Outstanding at end of period | 228,059 | 21.00 | 279,553 | 323,002 |
Options have a maximum contractual term often years. The aggregate intrinsic value and weighted average remaining contractual terms of options outstanding and options exercisable were as follows as of December 31, 2024.
| December 31, 2024 | |
|---|---|
| Aggregate intrinsic value (in millions)(1) | |
| Options outstanding | $— |
| Options exercisable | — |
| Weighted average remaining contractual term | |
| Options outstanding | 5.4 years |
| Options exercisable | 5.4 years |
(1)The aggregate intrinsic value of options outstanding and exercisable iszero, as all options are out of the money.
Employee Stock Purchase Plan
On June 3, 2020, the Board adopted the ZoomInfo Technologies Inc. 2020 Employee Stock Purchase Plan (the “ESPP”) that allows eligible employees to purchase shares of the Company's common stock at a discounted price, through payroll deductions of up to 15% of their eligible compensation and the IRS allowable limit per calendar year. The Compensation Committee of the Board administers the ESPP, including with respect to the frequency and duration of offering periods, the maximum number of shares that an eligible employee may purchase during an offering period, and, subject to certain limitations set forth in the ESPP, the per-share purchase price. Currently, the maximum number of shares that can be purchased by an eligible employee under the ESPP is 1,500 shares per offering period and there aretwo six-month offering periods that begin in the second and fourth quarter of each fiscal year. The purchase price for one share of common stock under the ESPP is currently equal to 90% of the fair market value of one share of common stock on the first trading day of the offering period or the purchase date, whichever is lower.
The maximum aggregate number of shares of the common stock that may be issued under the ESPP is no more than 7,500,000 shares (the “ESPP Plan Share Reserve”). The ESPP also contains a provision that will add an additional number of shares of common stock to the ESPP Plan Reserve on the first day of each year starting with January 1, 2021, equal to the lesser of (i) the positive difference between (x)1% of the number of shares of common stock outstanding on the last day of the immediately preceding fiscal year, and (y) the ESPP Plan Share Reserve on the last day of the immediately preceding fiscal year, and (ii) a lower number of shares of common stock as may be determined by the Board.
The fair value of the ESPP is determined using the Black-Scholes option pricing model with the following assumption ranges and fair value per unit:
| Year Ended December 31, 2024(1) | Year Ended December 31, 2023 | Year Ended December 31, 2022 | |
|---|---|---|---|
| Volatility | 56.1% | 50.4% to 67.6% | 71.9% to 77.0% |
| Expected term | 0.5 years | 0.5 years | 0.5 years |
| Risk-free rate | 5.4% | 5.3% to 5.4% | 2.2% to 4.7% |
| Expected dividends | —% | —% | —% |
| Weighted-average fair value per unit | $3.29 | $5.45 to $6.72 | $9.56 to $9.58 |
(1)The ESPP was suspended effective December 12, 2024, preventing the commencement of the December 15, 2024 offering.
The expected term for the purchases was based on the six-month offering period. We estimate the future stock price volatility based on the historical volatility of the Company with a lookback period commensurate with the expected term of the ESPP purchases. The risk-free rate is the implied yield available on U.S. Treasury zero-coupon bonds issued with a remaining term equal to the expected term.
The Company withheld $3.9 million, $7.0 million and $4.9 million worth of ESPP contributions for the years ended December 31, 2024, 2023 and 2022, respectively, on behalf of participating employees through payroll deductions included in Accrued expenses and other current liabilitieson our Consolidated Balance Sheets. The Company purchased 406,006,339,282 and 155,599 shares of common stock under the ESPP during the years ended December 31, 2024, 2023 and 2022, respectively. The Company recognized $1.6 million, $3.1 million and $1.8 million of equity-based compensation expense related to the ESPP for the years ended December 31, 2024, 2023 and 2022, respectively.
The Company suspended the ESPP effective December 12, 2024, such that the offering period which would otherwise have begun on December 15, 2024 did not commence.
HSKB Phantom Units
In December 2019, HSKB I adopted the HSKB Funds, LLC 2019 Phantom Unit Plan wherein HSKB may grant Phantom Units (“HSKB Phantom Units”) to employees of the Company. HSKB Phantom Units are recorded as compensation expense of the Company in accordance with the measurement and recognition criteria of ASC 718 for awards made by economic interest holders to employees of the Company. HSKB Phantom Units represent the economic equivalent ofone share of common stock in the Company. In connection with the Reorganization Transactions, all HSKB Phantom Units were moved from HSKB I to HSKB II. Within 30 days of the later of the date upon which a Phantom Unit vests, HSKB II must settle the HSKB Phantom Unit in exchange for either (1) cash or (2) common stock as determined by the HSKB Manager, in each case, equal to the fair market value of such Common Unit at the time of such exchange.
Unamortized Equity-based Compensation
As of December 31, 2024, unamortized equity-based compensation costs related to each equity-based incentive award described above is the following:
| ($ in millions, period in years) | Amount | Weighted Average Remaining Service Period |
|---|---|---|
| Restricted Stock Units | $224.8 | 2.3 |
| HSKB Phantom Units | 8.6 | 2.0 |
| Total unamortized equity-based compensation cost | $233.4 | 2.2 |
The total intrinsic value of profit interests and options that were exercised during the years ended December 31, 2024, 2023 and 2022 waszero, $0.1 million and $1.6 million, respectively. The total fair value of all other previously unvested equity-based awards that vested during the years ended December 31, 2024, 2023 and 2022 was $175.2 million, $213.6 million and $104.2 million, respectively.
Note 15 - Segment and Geographic Data
The Company operates asone operating segment, deriving revenues from customers by providing access to its go-to-market intelligence platform. The Company’s chief operating decision maker (“CODM”) is its Chief Executive Officer, who reviews financial information on a consolidated basis and uses net income (loss) for purposes of making operating decisions, assessing financial performance and allocating resources. The CODM also reviews total assets, as reported in our Consolidated Balance Sheets, and Purchases of property and equipment and other assets, as reported on our Consolidated Statements of Cash Flows.
Long-lived assets by geographical region are based on the location of the legal entity that owns the assets, which includes property and equipment, net and operating lease right-of-use assets, net. As of December 31, 2024, long-lived assets held in the United States and Israel were $179.5 million and $19.0 million, respectively, representing approximately 98% of the consolidated total. As of December 31, 2023, long-lived assets held in the United States and Israel were $120.2 million and $20.2 million, respectively, representing approximately 96% of the consolidated total.
Note 15 - Segment and Geographic Data (continued)
Contracts denominated in currencies other than the U.S. Dollar were not material for the years ended December 31, 2024, 2023, and 2022. Revenues derived from customers and partners located outside the United States, as determined based on the address provided by our customers and partners, accounted for approximately 12%,13%, and 12% of total revenue for the years ended December 31, 2024, 2023, and 2022, respectively. Revenue by geographic region is as follows:
| Year Ended December 31, | |||
|---|---|---|---|
| (in millions) | 2024 | 2023 | 2022 |
| United States | $1,065.1 | $1,080.1 | $961.5 |
| Rest of World | 149.2 | 159.4 | 136.5 |
| Total revenue | $1,214.3 | $1,239.5 | $1,098.0 |
The following table presents selected financial information with respect to the Company’s single operating segment for the years ended December 31, 2024, 2023, and 2022:
| Year Ended December 31, | |||
|---|---|---|---|
| (in millions) | 2024 | 2023 | 2022 |
| Revenue | $1,214.3 | $1,239.5 | $1,098.0 |
| Less: | |||
| Employee compensation expense (1) | 430.8 | 436.0 | 397.0 |
| Payroll tax and benefits expense | 87.3 | 77.7 | 71.7 |
| Technology expense | 53.0 | 46.3 | 37.6 |
| Marketing expense | 36.0 | 31.3 | 28.8 |
| Facilities expense | 28.8 | 20.2 | 15.1 |
| Bad debt expense | 42.8 | 33.8 | 5.7 |
| Hosting and infrastructure expense | 36.6 | 33.9 | 31.0 |
| Other segment items (2) | 315.9 | 220.2 | 247.5 |
| Depreciation and amortization expense | 85.7 | 80.6 | 87.8 |
| Interest expense, net | 39.3 | 45.2 | 47.6 |
| Loss on debt modification and extinguishment | 0.7 | 4.3 | — |
| Other loss (income), net | 26.1 | (178.8) | (66.4) |
| Income tax expense | 2.2 | 281.5 | 131.4 |
| Net income | $29.1 | $107.3 | $63.2 |
(1)Primarily includes employee-related salaries, bonuses, and commissions.
(2)Other segment items primarily include equity-based compensation expense.
Note 16 - Tax Receivable Agreements
In connection with the Reorganization Transactions, the Company entered into (i) the Exchange Tax Receivable Agreement with certain Pre-IPO OpCo Unitholders and (ii) the Reorganization Tax Receivable Agreement with the Pre-IPO Blocker Holders (collectively, the “Tax Receivable Agreements”). These Tax Receivable Agreements provide for the payment by the ZoomInfo Tax Group to such Pre-IPO Owners and certain Pre-IPO HoldCo Unitholders of 85.0% of the benefits, if any, that the ZoomInfo Tax Group actually realizes, or is deemed to realize in certain circumstances, as a result of utilization or deemed utilization of certain tax attributes and benefits covered by the Tax Receivable Agreements. The Company expects to benefit from the remaining 15.0% of the cash savings that it realizes.
Note 16 - Tax Receivable Agreements (continued)
The tax attributes and benefits covered by the Exchange Tax Receivable Agreement include (i) the ZoomInfo Tax Group’s allocable share of existing tax basis acquired in the IPO and (ii) increases in the ZoomInfo Tax Group’s allocable share of existing tax basis and tax basis adjustments that increased the tax basis of the tangible and intangible assets of the ZoomInfo Tax Group as a result of sales or exchanges of Holdings LLC Units for shares of common stock after the IPO, as well as certain other tax benefits, including tax benefits attributable to payments under the Exchange Tax Receivable Agreement.
The tax attributes and benefits covered by the Reorganization Tax Receivable Agreement include certain tax attributes of the Blocker Companies (including the ZoomInfo Tax Group’s allocable share of existing tax basis acquired in the Reorganization Transactions) and certain other tax benefits.
As of December 31, 2024 and 2023, the Company had a liability of $2,762.5 million and $2,818.0 million respectively, related to its projected obligations under the Tax Receivable Agreements. This liability, or a portion thereof, becomes payable as the tax attributes under the Tax Receivable Agreements reduce the Company’s current income tax liability which would otherwise have been due absent such tax attributes. The liability will be reduced to the extent the tax attributes are expected to expire or otherwise cannot be applied to reduce the Company’s tax liabilities. The TRA liability is classified as current or noncurrent based on the expected date of payment and is included on our Consolidated Balance Sheets under the captions Current portion of tax receivable agreements liability and Tax receivable agreements liability, net of current portion, respectively. During the years ended December 31, 2024, 2023, and 2022, we paid a total of $94.0 million, zero, and $12.2 million, respectively, pursuant to the Tax Receivable Agreements. The TRA remeasurement gains and losses are recorded within Other loss (income), net on our Consolidated Statements of Operations. For the year ended December 31, 2024, we recognized a TRA remeasurement loss of $38.5 million principally due to a revaluation for the blended state tax rate, an increase to the cumulative liability due to TRA Holders resulting from a reduction in the management allocation percent withheld, and interest expense accrued on the current portion of the TRA liability. During the year ended December 31, 2023, we recognized a TRA remeasurement gain of $160.7 million principally due to a reduction in our future blended state tax rate resulting from Massachusetts legislation enacted in 2023 and to reduce TRA-related attributes that did not achieve tax savings under the terms of the TRA. During the year ended December 31, 2022, we recognized a TRA remeasurement gain of $65.6 million due to revaluation for the blended state tax rate and updates to tax attributes.
Note 17 - Income Taxes
The components of income before provision for income taxes were as follows:
| Year Ended December 31, | |||
|---|---|---|---|
| (in millions) | 2024 | 2023 | 2022 |
| Domestic | $16.3 | $378.0 | $184.2 |
| Foreign | 15.0 | 10.8 | 10.4 |
| Income before income taxes | $31.3 | $388.8 | $194.6 |
The Provision for income taxes consisted of the following:
| Year Ended December 31, | |||
|---|---|---|---|
| (in millions) | 2024 | 2023 | 2022 |
| Current: | |||
| Federal | $0.4 | $— | $(2.7) |
| State | 0.6 | (0.3) | 0.4 |
| Foreign | 7.1 | 5.1 | 10.4 |
| Total current tax expense | $8.1 | $4.8 | $8.1 |
| Deferred: | |||
| Federal | $16.3 | $58.3 | $27.9 |
| State | (21.0) | 218.6 | 100.2 |
| Foreign | (1.2) | (0.2) | (4.8) |
| Total deferred tax expense (benefit) | $(5.9) | $276.7 | $123.3 |
| Provision for income taxes | $2.2 | $281.5 | $131.4 |
The following is a reconciliation between the U.S. federal statutory tax rate and our effective tax rate, expressed as a percentage of income before income taxes:
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Tax expense computed at U.S. federal statutory rate | 21.0% | 21.0% | 21.0% |
| Effect of: | |||
| State taxes, net of federal tax benefit | 26.5% | 6.9% | 7.5% |
| Effects of changes in state tax law and apportionment | (96.1)% | 35.6% | 35.0% |
| Effects of non-U.S. operations | 7.6% | 1.2% | (0.8)% |
| Stock-based compensation | 53.1% | 5.5% | 7.6% |
| Non-deductible executive compensation | 2.9% | 0.5% | 0.5% |
| Tax credits | (35.1)% | (1.4)% | (5.0)% |
| Changes in valuation allowance | 16.6% | 1.5% | —% |
| Unrecognized tax benefits | 6.4% | 1.9% | 2.6% |
| Non-deductible TRA Remeasurement | 0.6% | (0.2)% | 0.7% |
| Other non-deductible expenses | 3.7% | 0.1% | 0.2% |
| Other | —% | (0.2)% | (1.8)% |
| Effective income tax rate | 7.2% | 72.4% | 67.5% |
Significant components of the Company’s deferred tax assets and liabilities were as follows:
| Year Ended December 31, | ||
|---|---|---|
| (in millions) | 2024 | 2023 |
| Deferred tax assets: | ||
| Capitalized research expenditures | $92.5 | $64.6 |
| Operating lease liabilities | 35.9 | 19.9 |
| Stock-based compensation | 14.9 | 16.6 |
| Goodwill | 3,145.9 | 3,339.3 |
| Interest expense carryforwards | 35.0 | 33.6 |
| Net operating loss carryforwards | 443.7 | 297.0 |
| Credit carryforwards | 23.6 | 14.6 |
| Other | 13.6 | 9.9 |
| Total deferred tax assets | $3,805.1 | $3,795.5 |
| Valuation allowance | (10.9) | (5.7) |
| Deferred tax assets, net of valuation allowance | $3,794.2 | $3,789.8 |
| Deferred tax liabilities: | ||
| Deferred commissions | $17.0 | $11.1 |
| Operating lease right-of-use assets | 20.4 | 15.9 |
| Acquired intangible assets | 33.1 | 44.3 |
| Cash flow hedge - Accumulated Other Comprehensive Income | 5.1 | 9.2 |
| Deferred tax on foreign earnings | 2.4 | 1.9 |
| Other | 1.0 | 2.2 |
| Total deferred tax liabilities | $79.0 | $84.6 |
| Net deferred tax assets | $3,715.2 | $3,705.2 |
As of December 31, 2024, the Company had gross U.S. federal net operating losses of $1,677.4 million, excess business interest expense carryforwards under IRC Sec. 163(j) of $148.6 million, and tax credit carryforwards of $27.9 million. As of December 31, 2023, the Company had gross U.S. federal net operating losses of $1,119.7 million, excess business interest expense carryforwards under IRC Sec. 163(j) of $143.8 million, and tax credit carryforwards of $15.8 million. The Company’s federal net operating losses and excess business interest carryforwards can be carried forward indefinitely, with the exception of $6.4 million of net operating losses generated before 2018 which expire between 2034 and 2037. Our federal tax credits will begin to expire in 2037. As of December 31, 2024, the Company had $1,647.6 million of gross state net operating losses, of which $65.2 million expires before 2035, $1,430.7 million expires between 2035 and 2044, and the remaining $151.7 million remains available to be carried forward indefinitely. The Company also had $1.1 million of state tax credits, which begin to expire in 2030.
After consideration of all positive and negative evidence, including scheduled reversals of deferred tax assets and liabilities, projected future taxable income, tax planning strategies, and results of recent operations, management determined that it is more likely than not that a portion of our deferred tax assets will not be realized. As a result, we recorded a valuation allowance of $10.9 million and $5.7 million as of December 31, 2024 and 2023, respectively. The increase in the valuation allowance as of December 31, 2024 as compared to December 31, 2023 is primarily due to establishing valuation allowances on certain state and local net operating losses and tax credits that are not more likely than not to be realized due to state-specific limitations on utilization and carryforward periods.
We regularly evaluate the positions taken, or expected to be taken on tax returns, to determine if they constitute uncertain tax positions. Unrecognized tax benefits are reflected in our Consolidated Balance Sheets as a reduction of Deferred tax assets. If recognized, all unrecognized tax benefits at December 31, 2024 would affect the effective tax rate. It is not anticipated that any of the unrecognized tax benefits will be recognized in the next twelve months.
A reconciliation of the Company’s beginning and ending amount of unrecognized tax benefits is as follows:
| Year Ended December 31, | |||
|---|---|---|---|
| (in millions) | 2024 | 2023 | 2022 |
| Beginning balance | $12.6 | $5.1 | $— |
| Gross increases in unrecognized tax benefits – prior year tax positions | 1.0 | 11.4 | 1.3 |
| Gross decreases in unrecognized tax benefits – prior year tax positions | (0.6) | (5.3) | — |
| Gross increases in unrecognized tax benefits – current year tax positions | 1.6 | 1.4 | 3.8 |
| Ending balance | $14.6 | $12.6 | $5.1 |
Our policy is to record interest and penalties related to income taxes as a component of income tax expense. No interest or penalties have been accrued with respect to uncertain tax positions through December 31, 2024, as the Company has no tax due because of significant net operating loss carryforwards.
The OECD has issued administrative guidance providing transition and safe harbor rules around the implementation of the Pillar Two Model Rules, which call for a minimum tax of 15% on large corporations. A number of countries, including the United Kingdom, are currently proposing or have enacted legislation to implement core elements of the Pillar Two proposal. We are closely monitoring developments and evaluating their potential impact. Enactments effective in 2024 did not have a significant impact on our 2024 financial results, nor do we anticipate a significant impact on our financial results during the transition period due to safe harbor relief.
Our foreign earnings are available for repatriation to the United States, and we accrue a liability for the tax we expect to apply upon repatriation. As of December 31, 2024 and 2023, we accrued $2.4 million and $1.9 million, respectively, for foreign withholding tax, which were included in Deferred tax liabilities in our Consolidated Balance Sheets.
The Company files income tax returns in the United States and various foreign jurisdictions where the Company has operations. The Company remains open to examination in the United States from 2014, in Israel from 2021, and in the United Kingdom from 2023. We consider our major state jurisdictions to be California, New York and Massachusetts, and remain subject to examination in these states from 2015, 2017, and 2021, respectively. One of the Company’s subsidiaries is undergoing a federal tax audit in the United States with respect to its 2021 tax year.
Note 18 - Subsequent Events
Management has evaluated subsequent events from December 31, 2024 through the date the financial statement was available to be issued and has determined there are no material subsequent events that require disclosure other than those described below and in Note 10 - Commitments and Contingencies.
In February 2025, our board of directors authorized an additional $500.0 million in repurchases under the Share Repurchase Program. Refer to Note 11 - Stockholders' Equity for additional information regarding the Share Repurchase Program.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.